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Abstract 
 
A series of neutral and cationic rhodium and iridium(I) complexes based on hemilabile O-donor and 
N-donor functionalized NHC ligands having methoxy, dimethylamino and pyridine as donor 
functions have been synthesized. The hemilabile fragment is coordinated to the iridium center in the 
cationic complexes [Ir(cod)(MeImR)]+ (R = pyridin-2-ylmethyl, 3-dimethylaminopropyl) but 
remains uncoordinated in the complexes [MBr(cod)(MeImR)], [M(NCCH3)(cod)(MeImR)]+ (M = 
Rh, Ir; R = 2-methoxyethyl and 2-methoxybenzyl) and [IrX(cod)(MeImR)] (X = Br, R = pyridin-2-
ylmethyl; X = Cl, R = 2-dimethylaminoethyl, 3-dimethylaminopropyl). The structure of 
[IrBr(cod)(MeIm(2-methoxybenzyl))] has been determined by X-ray diffraction. The iridium 
complexes are efficient precatalysts for the transfer hydrogenation of cyclohexanone in 2-
propanol/KOH. A comparative study has shown that cationic complexes are more efficient than the 
neutral, and also that complexes having O-functionalized NHC ligands provide much more active 
systems that the corresponding N-functionalized ligands with TOFs up to 4600 h-1. The complexes 
[Ir(NCCH3)(cod)(MeImR)]+ (R = 2-methoxyethyl and 2-methoxybenzyl) have been successfully 
applied to the reduction of several unsaturated substrates as ketones, aldehydes, α,β-unsaturated 
ketones and imines. The investigation of the reaction mechanism by NMR and MS has allowed the 
identification of relevant alkoxo intermediates [Ir(OR)(cod)(MeImR)] and the unsaturated hydride 
species [IrH(cod)(MeImR)]. The β-H elimination in the alkoxo complex [Ir(OiPr)(cod)(MeIm(2-
methoxybenzyl))] leading to hydrido species has been studied by DFT calculations. An interaction 
between the β-H on the alkoxo ligand and the oxygen atom of the methoxy fragment of the NHC 
ligand, which results in a net destabilization of the alkoxo intermediate by a free energy of +1.0 
kcal/mol, has been identified. This destabilization facilitates the β-H elimination step in the catalytic 
process and could explain the positive effect of the methoxy group of the functionalized NHC 
ligands on the catalytic activity. 
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Introduction 
N-Heterocyclic carbenes (NHCs) have attracted much interest as ligands for homogeneous 
catalysis. NHC ligands have proved to be efficient ancillary ligands because of their strong 
coordination ability that imparts to the metal complexes an adequate balance between stability and 
activity, and their tunable character that allows for the control of the sterical and electronic 
properties on the metal center.1 These ligands are easily accessible from imidazolium salts2 and a 
large number of NHCs precursors: simple, functionalized, bis- or tris-NHC, with different topologies 
have been prepared that, in combination with well established coordination methodologies, has led 
to the preparation of a range of transition metal complexes with different geometries and potential 
catalytic applications.3 
Hemilabile ligands can play a dual role in a catalyst since they can easily enable coordinative sites 
at the metal center and, at the same time, protect the coordination sites by a dynamic “on and off” 
chelating effect.4 Although the most studied hemilabile ligands are functionalized phosphines 
containing O and N donor sets, functionalized NHC ligands can also exhibit hemilability5 and 
represent a good alternative for the preparation of new compounds with application in homogenous 
catalysis.6 In this context, a number of complexes containing functionalized NHCs ligands in which 
a labile donor function (ether, thioether, alkoxy, pyridine, amine, amido, etc.) is attached to a 
strongly bonded carbene moiety have been synthesized. In fact, the hemilabile character of several 
O, N or S-functionalized NHCs ligands have been demonstrated7 and in some cases, an active role of 
the hemilabile fragment has been identified in several catalytic processes.8 
Transfer hydrogenation is a powerful strategy for the reduction of unsaturated C=O and C=N 
compounds and a range of alcohols and amines are accessible by transfer hydrogenation under mild 
reaction conditions.9 Transfer hydrogenation is a valuable and atom efficient reaction with evident 
 
Jiménez, Fernández-Tornos, Pérez-Torrente, Modrego, Winterle, Cunchillos, Lahoz and Oro, manuscript for Organometallics 
 
 
 
4 
economic and environmental advantages, as it avoids the use of dihydrogen pressure or hazardous 
reducing agents by using nontoxic hydrogen donors as alcohols, formic acid, hydrazine, etc.10 
The most active and selective hydrogen transfer catalysts, particularly in enantioselective 
reductions, are ruthenium, rhodium and iridium complexes. In particular, it is noteworthy to mention 
Noyori’s ruthenium catalysts with chiral tetradentate ligands, and those arene complexes based on 
chiral β-aminoalcohol or N-tosyl-ethylenediamine ligands operating through a bifunctional metal-
ligand mechanism.11 Efficient rhodium and iridium hydrogen transfer catalysts are mainly based 
both on phosphine and N-donor ligands,10 although NHC ligands have also been applied to the 
design of hydrogen transfer catalysts. It has been found that, in contrast to phosphine based catalysts, 
iridium-NHC complexes are more active than their Rh-NHC analogues and accordingly, a number of 
highly efficient iridium catalyst have been recently reported.12 In particular, air-stable iridium(III) 
bis-carbene complexes were found to be active catalysts for transfer hydrogenation of ketones, 
aldehydes and imines at low catalyst loading.13  
Our interest is focused on the synthesis and catalytic applications of transition metal complexes 
containing heteroditopic ligands of hemilabile character that incorporate strong electron donors, such 
as phosphines and carbenes. We have recently reported the application of cationic rhodium(I) 
complexes containing flexible hemilabile functionalized phosphine ligands of the type Ph2P(CH2)nZ 
(Z = OR, NR2, SR)14 for the stereoregular polymerization of phenylacetylene,8a and the 
regioselective anti-Markovnikov oxidative amination of olefins.15 Mechanistic studies led to 
discover the active role of the hemilabile fragment of the ligands in the initiation process of the 
polymerization reactions leading to high average molecular weights.8a,16 In addition, remarkable 
catalyst efficiency in hydroamination was observed with those catalytic systems based on the ligand 
(3-ethoxypropyl)diphenylphosphine, Ph2P(CH2)3OEt.  
It has come to our attention that the catalyst efficiency in transfer hydrogenation of ketones by 
sterically demanding unsymmetrically N,N’-substituted benzimidazol-2-ylidene iridium(I) 
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[IrBr(cod)(NHC)] complexes was improved when using NHC ligands having a 2-methoxyethyl 
substituent.17 In same way, highly effective iridium(I) hydrogen transfer catalysts based on 
unsymmetrical 2-methoxyphenyl donor-functionalized expanded ring NHCs have been recently 
reported.18 It becomes evident that the presence of a hemilabile fragment on the catalyst structure 
has a considerable impact on hydrogen transfer catalytic activity. Although a possible hemilabile 
chelating effect at the metal center for the stabilization of coordinatively unsaturated catalytic 
intermediates could account for the enhanced activity, the promotion of directing effects with the 
substrate or the stabilization of polar catalytic intermediates through weak interactions can not be 
ruled out. 
In order to investigate further this hemilabile effect we report herein on the synthesis and catalytic 
activity in hydrogen transfer of a series of rhodium and iridium complexes containing hemilabile O- 
and N- donor functionalized NHCs ligands. Interestingly, a relationship between the donor function, 
the flexibility of the backbone and the length of the linker in the ligands, with the catalytic activity 
has been observed. 
 
Results and Discussion 
Synthesis of Precursors for Hemilabile NHC Ligands. The imidazolium salts precursors for 
selected O- and N-donor functionalized N-heterocyclic carbene ligands were prepared by alkylation 
of 1-methylimidazole with the corresponding functionalized alkyl bromide or chloride (Chart 1). The 
imidazolium salts precursors for flexible hemilabile NHC ligands, [MeImH(CH2)2OMe]Br (1)19 and 
[MeImH(CH2)nNHMe2)]Cl2 (n = 2, 4; n = 3, 5),6a were prepared by alkylation with 1-bromo-2-
methoxyethane and the corresponding chloro-alkyl-dimethylamine hydrochloride derivatives, 
respectively, following the reported methods. In the same way, [MeImH(pyridin-2-ylmethyl)]Br (3), 
a precursor for a rigid N-functionalized NHC ligand, was prepared using 2-(bromomethyl)pyridine 
as alkylating reagent.20 The new salt 1-(2-methoxybenzyl)-3-methyl-1H-imidazol-3-ium bromide (2)  
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precursor of a related rigid O-functionalized NHC ligand, was synthesized by alkylation of 1-
methylimidazole with 2-methoxybenzyl bromide, prepared by bromination of 2-methoxybenzyl 
alcohol,21 in toluene following the procedure described for the N-tert-butyl derivative.22 
[MeImH(2-methoxybenzyl)]Br (2) was isolated as a white hygroscopic solid in good yield and 
characterized by elemental analysis, mass spectrometry (ESI-MS), and 1H and 13C{1H} NMR 
spectroscopy. The characteristic downfield shifted resonances of the NCHN imidazolium fragment 
were observed in the 1H and 13C{1H} NMR spectra at δ 10.37 and 137.41 ppm, respectively. 
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Chart 1. Imidazolium salt precursors for functionalized NHC ligands. 
 
Synthesis of Neutral Iridium(I) and Rhodium(I) Complexes with Functionalized NHC 
Ligands. The attempts to prepare iridium and rhodium (I) complexes using the free NHC ligands 
generated in situ by deprotonation of the imidazolium salts were unsuccessful, probably due to the 
acidity of the methylene protons. However, the direct deprotonation of the methoxo ligands in the 
dinuclear complexes [{M(µ-OMe)(cod)}2] provide access to neutral mononuclear complexes 
containing the functionalized NHC ligands. In fact, reaction of the imidazolum salts with 0.5 equiv. 
of [{M(µ-OMe)(cod)}2] (M = Rh, Ir) in tetrahydrofuran gave orange solutions from which the 
bromo complexes [MBr(cod)(MeIm(CH2)2OMe)] (M = Ir, 6; M = Rh, 8) and [MBr(cod)(MeIm(2-
methoxybenzyl))] (M = Ir, 7; M = Rh, 9) were isolated as orange solids in good yield (Chart 2). This 
methodology is also applicable for the synthesis of [IrBr(cod)(MeIm(pyridin-2-ylmethyl))] (10). The 
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synthesis of iridium complexes [IrCl(cod)(MeIm(CH2)nNMe2)] (n = 2, 11; n = 3, 12) containing 
dimethylamino-functionalized NHC ligands was carried out in two steps, through the intermediate 
cyclooctadienedichloroiridate(I) [MeImH(CH2)nNMe2][IrCl2(cod)] salts, following the same strategy 
used for the preparation of analogue rhodium compounds.6a Reaction of the ammonium-imidazolium 
salts [MeImH(CH2)nNMe2]Cl·HCl with [{Ir(µ-OMe)(cod)}2] resulted in the formation of the amino-
imidazolium salts [MeImH(CH2)nNMe2][IrCl2(cod)], which were further deprotonated by using 
NaH/H2O to give the corresponding neutral compounds. 
The complexes 6−12 have been fully characterized by spectroscopic means. In addition, their 
neutral character was confirmed by conductivity measurements in acetone and the MALDI-TOF 
mass spectra that showed peaks at m/z corresponding to the molecular ion and the cations resulting 
from the lost of the halide ligand. 
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Chart 2. Neutral rhodium and iridium(I) complexes with functionalized NHC ligands. 
 
The 1H NMR spectra of the new iridium/rhodium(I) complexes 6−12 showed no low-field signals 
attributable to the acidic NCHN protons, which confirm the deprotonation of the imidazolium 
fragment. Noteworthy, the coordination of the functionalized-NHC ligands to the metal center 
becomes evident as low-field resonances around δ 180 ppm (doublet for rhodium complexes 8-9, 
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JRh-C ≈ 50 Hz) were observed in the 13C{1H} NMR spectra. Most of the complexes showed two 
resonances for the vinylic protons of the cod ligand in the 1H NMR spectra at δ ≈ 4.5 and ≈ 3.0 ppm 
(complex 8 exhibits four resonances), the upfield resonance corresponding to the =CH protons trans 
to the NHC ligand. This effect has also been observed in Ir(I)-cod-phosphine complexes23 although 
the chemical shift difference between the vinylic protons is smaller than in related Ir(I)/Rh(I)-cod-
NHC complexes.12e, 24 However, the 13C{1H} NMR spectra of the complexes featured four 
resonances for the olefinic carbons of the cod ligand which is indicative of the lack of an effective 
symmetry plane in the molecules, probably as a result of the hindered rotation about the carbene-
metal bond enforced by the presence of the sidearm in the hemilabile NHC ligands cis to large halide 
and cod ligands. As a consequence, the methylenic protons of the sidearm of NHC ligands were 
found to be diastereotopic and two distinct resonances for the =CH protons and carbons of the 
imidazole fragment were observed in the NMR of the complexes. 
In order to get detailed information on the structural parameters in these complexes, the X-ray 
determination of the molecular structure of [IrBr(cod)(MeIm(2-methoxybenzyl))] (7) was carried 
out. The molecular structure of 7 and the more significant bond distances and angles are shown in 
Figure 1. The coordination geometry around the iridium center,- formed by the coordination to the 
metal of the two olefinic bonds of the cyclooctadiene ligand, the carbon atom of the NHC ligand and 
the bromide atom,- is slightly distorted square-planar, as evidenced by the trans bond angles Br–Ir–
C(17)/C(18) 178.72(12) and C(1)–Ir(1)–C(13)/C(14) 176.11(18)º. The most remarkable structural 
feature involves the different olefinic bond distances observed (Ir–M(1) 2.072(5), C(13)–C(14) 
1.376(6) Å versus Ir–M(2) 1.980(4), C(17)–C(18) 1.409(6) Å, M(1) and M(2) represent the 
midpoints of the olefinic bonds C(13)-C(14) and C(17)-C(18), respectively), most likely as a clear 
consequence of the high structural trans effect of the NHC ligand. 
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Figure 1. Molecular structure of complex [IrBr(cod)(MeIm(2-methoxybenzyl))] (7) (Hydrogen 
atoms have been omitted for clarity). Selected bond lengths (Å) and angles (º): Ir–Br 2.4904(6), Ir–
C(1) 2.035(4), Ir–C(13) 2.192(4), Ir–C(17) 2.105(4), Ir–C(14) 2.174(4), Ir–C(18) 2.098(4), N(1)–
C(1) 1.357(5), N(2)–C(1) 1.351(5), N(1)–C(2) 1.385(6), N(2)–C(3) 1.390(5), N(1)–C(4) 1.452(5), 
N(2)–C(5) 1.463(5), C(13)–C(14) 1.376(6), C(17)–C(18) 1.409(6), Br–Ir–C(1) 89.03(10), M(1)–Ir–
M(2) 87.26(19), Ir–C(1)–N(1) 125.4(3), Ir–C(1)–N(2) 130.4(3), N(1)–C(1) –N(2) 104.2(3). 
 
Synthesis of Cationic Rhodium(I) and Iridium(I) Complexes with Functionalized NHC 
Ligands. The coordination of the amino/pyridine donor set of the functionalized NHC ligands can 
be accomplished, between other methods, by abstraction of the halide ligand in the neutral 
complexes.25 However, the coordination of the methoxy fragment by abstraction of the bromo ligand 
in the complexes containing O-functionalized NHC ligands was unsuccessful and the presence of 
acetonitrile is required for the stabilization of the cationic complexes.  
Reaction of the bromo complexes [MBr(cod)(MeIm(CH2)2OMe)] (6, 8) and [MBr(cod)(MeIm(2-
methoxybenzyl))] (7, 9) with AgBF4 in acetone in the presence of 1 equiv. of CH3CN at room 
temperature resulted in the precipitation of AgBr and the formation of yellow solutions of the 
cationic complexes [M(NCCH3)(cod)(MeIm(CH2)2OMe)][BF4] (M = Ir, 13; M = Rh, 15) and 
[M(NCCH3)(cod)(MeIm(2-methoxybenzyl))][BF4] (M = Ir, 14; M = Rh, 16) which were isolated as 
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10 
microcrystalline yellow solids in good yield (Chart 3). The more convenient synthesis of complexes 
[Ir(cod)(MeIm(pyridin-2-ylmethyl))][BF4] (17) and [Ir(cod)(MeIm(CH2)3NMe2)][BF4] (18) relies on 
the NHC transfer from the silver complexes [AgCl(NHC)]x, generated in situ, to the cyclooctadiene 
solvato [Ir(cod)(OCMe2)2]+ species containing labile acetone ligands. 
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Chart 3. Cationic rhodium and iridium(I) complexes with functionalized NHC ligands. 
 
The conductivity measurements in acetone solutions were in agreement with the presence of 1:1 
electrolytes and the MALDI-TOF mass spectra showed the molecular ion (compounds 17 and 18) or 
the ion resulting from the lost of the acetonitrile ligand. The presence of an acetonitrile ligand in 
complexes 13-16, which was observed at δ ≈ 2.4 ppm in the 1H and at δ ≈ 130 and 3 ppm in the 
13C{1H} NMR spectra, suggests an uncoordinated methoxy moiety in the complexes. In contrast, no 
coordinated solvents were observed in the NMR spectra of complexes 17 and 18, even when the 
reaction was conducted in the presence of acetonitrile, from which the coordination of the pyridine 
and dimethyl amino moieties was inferred. On the other hand, the large downfield shift observed for 
the resonance of the >CH2 attached to the NHC ring compared to the neutral precursor in the 
13C{1H} NMR spectra (ca. 9 and 14 ppm, respectively) is a diagnostic for the coordination of the 
hemilabile fragment in the complexes.15 
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Transfer Hydrogenation Catalysis: Preliminary Screening. The neutral and cationic rhodium 
and iridium complexes with N- and O-functionalized NHCs have been tested as catalysts for transfer 
hydrogenation of unsaturated substrates. The reduction of cyclohexanone to cyclohexanol was 
chosen as model reaction to explore the catalytic performance of the different compounds (Equation 
1) and the reaction conditions were optimized using [IrBr(cod)(MeIm(2-methoxybenzyl))] (7) as 
catalyst precursor. 2-Propanol was used as hydrogen source because of its favorable properties, 
particularly a stable, non toxic solvent with a moderate boiling point. Standard catalyst loading of 
0.1 mol % and KOH (0.5 mol %) were routinely used. Other inorganic bases as Cs2CO3 or Kt-BuO 
were found to provide less active catalytic systems with reaction times over 25% higher for the same 
level of conversion under the same experimental conditions. On the other hand, although 
KN(Si(CH3)3)2 reduces the reaction time more or less in the same proportion, the cheaper KOH was 
selected as base because there is more reported data in the literature. The reaction times required to 
reach conversions over 90% (determined by GC using mesitylene as internal standard) and the 
average turnover frequencies (TOF) for all the examined catalysts are shown in Table 1. The 
temperature has a strong influence on the catalyst performance and a sharp decrease in the catalytic 
activity was observed when the temperature was lowered from 80 to 40 oC under the standard 
conditions using 7 as catalyst precursor (Table 1, entries 2–4). 
 
O
OH 0.1
 mol%
 catalyst
OH
O
(1)
 
 
The neutral iridium complexes with N-functionalized NHCs 10-12 were found to be moderately 
active in the transfer hydrogenation of cyclohexanone to cyclohexanol with compound 
[IrCl(cod)(MeIm(CH2)2NMe2)] (11), having a NHC ligand with a flexible arm, the more active 
(entries 5-7). It is noteworthy that a notable increase in the catalytic activity was observed with the 
 
Jiménez, Fernández-Tornos, Pérez-Torrente, Modrego, Winterle, Cunchillos, Lahoz and Oro, manuscript for Organometallics 
 
 
 
12 
corresponding cationic complexes 17 and 18, having NHC ligands κ2-C,N coordinated, which 
exhibited a TOF of ca. 240 h-1 (entries 10-11). 
 
Table 1. Catalytic Hydrogen Transfer from 2-Propanol to Cyclohexanone with Iridium and 
Rhodium Complexes having N- and O-functionalized NHC ligands.a, b 
entry catalyst time (min) conversion(%) TON TOFc/ h-1 
1 M = Ir 6 110 90 900 490 
2  7 72 98 989 824 
3  7d 320 96 961 180 
4  7e 1500 97 972 39 
5  10 1730 90 904 31 
6  11 408 94 941 138 
7  12 1360 91 910 40 
8  13 35 90 907 1555 
9  14 12 92 924 4622 
10  17 220 91 910 248 
11  18 240 93 934 234 
12 M = Rh 8f 90 98 50 33 
13  9f 180 97 49 16 
14  15f 120 98 50 25 
15  16f 210 98 50 14 
a Reaction conditions: catalyst/substrate/KOH ratio of 1/1000/5, [catalyst]o = 1 x 10-3 M in 2-
propanol at 80 °C. b The reactions were monitored by GC using mesitylene as internal standard. c 
Average turnover frequency (mol of product/mol of catalyst per hour) determined at the reaction 
time. d T = 60 ºC. e T = 40 ºC. f Catalyst/subtract/base ratio of 1/100/5. 
 
The neutral bromo iridium complexes with O-functionalized NHCs, 6 and 7, are far more active  
than the related neutral N-functionalized precursors (entries 1 and 2), with compound 
[IrBr(cod)(MeIm(2-methoxybenzyl))] (7), having a NHC with a less flexible arm, the more active 
with a TOF of 824 h-1. Interestingly, the corresponding cationic complexes having a labile 
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acetonitrile ligand and methoxy functionalized free arms, [Ir(NCCH3)(cod)(MeIm(CH2)2OMe)]+ 
(13) and [Ir(NCCH3)(cod)(MeIm(2-methoxybenzyl))]+ (14), were highly efficient catalyst precursors 
giving TOFs of 1555 and 4622 h-1 (entries 8 and 9), respectively. These results points out the 
superior catalytic performance of cationic complexes and highlights the positive influence of 
O-functionalized NHC ligands having a donor set with weak coordination ability. In addition, the 
outstanding catalytic activity of 14, with a 2-methoxybenzyl substituent, suggests that the flexibility 
of the functionalized arm of the NHC ligand also influences the catalytic activity. 
The related rhodium complexes having O-functionalized NHCs were poor catalysts, even using 1 
mol % catalyst loading, which is agreement with the general observed trend that, opposite to the 
phosphine-based catalysts,10 iridium-carbene complexes are more active in transfer hydrogenation 
than their rhodium analogues.26,13c In sharp contrast with the iridium precursors, the neutral 
complexes 8 and 9 are slightly more active than the corresponding cationic complexes 15 and 16 
(entries 12-15) with the flexible ligands giving a somewhat superior activity. 
The catalytic activity exhibited by 13 and 14 is significantly higher than the observed for related 
iridium(I)/unfunctionalized-NHC complexes, as for example [Ir(cod)py(ICy)]+ (ICy = 1,3-
dicyclohexylimidazol-2-ylidene),12e that gave a TOF of 300 h-1 for the transfer hydrogenation of 
cyclohexanone at the same catalyst loading, benzannulated-NHC iridium(I) complexes (TOFs from 
70 to 250 h-1) or [Ir(OSiMe3)(cod)(IMes)] (TOF = 125 h-1) transfer hydrogenation catalysts 
previously reported.12,17,26 On the other hand, the catalytic activity of both precursors is even higher 
that the shown by a number of Ir(I) complexes having unsymmetrical 2-methoxyphenyl donor 
functionalized NHC ligands which exhibited turnover frequencies up to 400  
h-1 for the transfer hydrogenation of 4-bromoacetophenone.18 
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Figure 2. Time dependence of the catalytic transfer hydrogenation of cyclohexanone using 0.1 mol 
% catalyst (6, 7 and 14) in 2-propanol at 80 oC with KOH as base. 
 
The transfer hydrogenation of cyclohexanone with the catalyst precursors 6, 7 and 14, under 
standard conditions, was monitored by GC analysis taking 0.1 mL aliquots of the reaction mixture at 
intervals of 5 min. As can be observed in the conversion vs time plots no induction period was 
detected as cyclohexanone reduction was observed immediately after thermal equilibration of the 
reactant mixture (Figure 2). Interestingly, quantitative conversion was achieved in less than 15 
minutes for compound 14, the more efficient catalyst precursor in this series. A plot of the 
ln[cyclohexanone] vs time gave a linear fit that is representative of a pseudo-first-order kinetic 
behavior with the slope of the line corresponding to the observed first-order rate constant k(min-1) 
(Table 2 and Supporting information). The TOF50 (turnover frequency at 50% of conversion) 
calculated from the kinetic data for this catalyst is as high as 8750 h-1. The catalyst reaction order for 
the transfer hydrogenation of cyclohexanone with 2-propanol at 80 oC has been determined using 
catalyst precursor 14. Thus, several catalytic runs were carried out at different catalyst 
concentrations using substrate/catalyst ratios of 1000:1, 2500:1, 5000:1 and 7500:1 in order to 
determine the corresponding first-order rate constants (Table 2). The representation of lnk vs ln[Ir] 
gave a straight line with slope 1.10 (R2 = 0.993) in agreement with the expected first-order 
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15 
dependence on the catalyst indicating no loss of catalytic activity due to catalyst deactivation (see 
Supporting information).27 
 
Table 2. Calculated Rate Constants for the Transfer Hydrogenation of Cyclohexanone with Catalyst 
6, 7 and 14. a, b 
Catalyst Catalyst loading 
(mol%) 
[Ir] (mol L-1) k (min-1) R2 
6 0.1 1.0 x 10-3 2.38 ± 0.06 x 10-2 0.991 
7 0.1 1.0 x 10-3 3.31 ± 0.08 x 10-2 0.994 
14 0.1 1.0 x 10-3 2.08 ± 0.02 x 10-1 0.999 
14 0.04 4.0 x 10-4 8.6 ± 0.2 x 10-2 0.996 
14 0.02 2.0 x 10-4 3.95 ± 0.08 x 10-2 0.999 
14 0.013 1.33 x 10-4 2.19 ± 0.06 x 10-2 0.993 
a Reaction conditions: cyclohexanone 5 mmol, catalyst/KOH ratio of 1/5 in 2-propanol at 80 °C. 
b The reactions were monitored by GC using mesitylene as internal standard. 
 
Catalytic Transfer Hydrogenation of Unsaturated Substrates Catalyzed by Iridium 
Complexes with O-donor functionalized NHC Ligands. Following these initial studies, we have 
examined the performance of the efficient cationic iridium catalysts containing O-donor 
functionalized NHC ligands, [Ir(NCCH3)(cod)(MeIm(CH2)2OMe]+ (13) and 
[Ir(NCCH3)(cod)(MeIm(2-methoxybenzyl))]+ (14), for the transfer hydrogenation of several 
unsaturated substrates, and the results are summarized in Table 3. In addition, the catalytic activity 
of the neutral bromo complexes 6 and 7 has been also studied in some cases for comparative 
purposes. 
Acetophenone was efficiently reduced although at moderate rates compared to the observed with 
the smaller and geometry constrained substrate cyclohexanone (entries 1–3). Interestingly, the same 
activity trend 7 < 13 < 14 was also observed in the transfer hydrogenation of acetophenone, being 
the catalyst having a 2-methoxybenzyl functionalized NHC ligand the more active with a TOF of 
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683 h-1. 4-Bromacetophenone was reduced to 1-(4-bromophenyl)ethanol by 14 at similar rate with 
no observable dehalogenation due to Ar-X activation (entry 4). 
Table 3. Catalytic Transfer Hydrogenation of Unsaturated Substrates Catalyzed by Iridium 
Complexes with O-donor-functionalized NHC Ligands.a, b 
entry substrate product catalyst time 
(min) 
conversion 
(%) 
TOFc/ h-
1 
       1 O
 
OH
 
7 180 91 303 
2 13 110 91 497 
3 14 80 90 683 
       
4 H
O
Br  
OH
Br  
14 85 91 645 
       5d 
H
O
 
 
OH
 
7 35 95 1635 
6d 14 25 96 2318 
       
7d H
O
 
OH
 
14 130 95 438 
       
8d 
H
O
6  OH6  
14 80 96 720f 
       9 
  
6 120 94 471 
10 7 340 45 80 
11 14 2470 63 15 
       12 O
 
O
 
6 180 96 320 
13 7 30 90 1817 
14 14 50 96 1163 
       15 
N
 
N
H
 
13 200 94 281 
16 
 
14 60 93 931 
17e N
 
N
H
 
14 345 93 161 
a Reaction conditions: catalyst/substrate/KOH ratio of 1/1000/5, [catalyst]o = 1 x 10-3 M in 2-propanol at 80 °C. b The 
reactions were monitored by GC using mesitylene as internal standard. c Average turnover frequency (mol of 
product/mol of catalyst per hour) determined at the reaction time. d Catalyst/substrate/KOH ratio of 1:1000:10. 
e Catalyst/substrate/KOH ratio of 1:100:5. 
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In general, aldehydes are hard to reduce by hydrogen transfer catalysis. The reduction of aldehydes 
to primary alcohols via transfer hydrogenation can be problematic due to the possible substrate 
decarbonylation resulting in deactivation of the catalysts. In addition, the CH α to the carbonyl are 
susceptible to deprotonation under the required basic conditions to give aldol and related products 
resulting from condensation. In any case, beyond the activity and chemoselectivity issues the higher 
redox potentials of aldehydes compared to ketones shifts the transfer hydrogenation equilibrium 
towards the formation of the primary alcohol products. Benzaldehyde was successfully reduced to 
phenylmethanol by the neutral complex 7 with no detectable aldol product in spite of using a 
strongest basic media (entry 5). The cationic complex 14 showed an outstanding catalytic activity 
with a TOF of 2318 h-1, calculated at 96% of conversion, under the same conditions (entry 6). 
Standard activities for most transition metal catalysts are around a few hundred turnovers per hour, 
however, the remarkable activity of 14 is of the same order that the exhibited by bis-NHC -Ir(III)13a 
or NHC-hidroxo-Os(II)28 complexes but lower than for example, [RuCl(CNN)(dppb)] (HCNN = 6-
(4′-methylphenyl)-2-pyridylmethylamine; dppb =  Ph2P(CH2)4PPh2)29 or [Cp*IrCl(µ-Cl)]2 in the 
presence of diamines30 in aqueous media which show TOFs up to 105 h-1. 
Transfer hydrogenation of aliphatic aldehydes by 14 took place at lower rates. 3-Phenylpropanal, 
an enolizable aldehyde, was quantitative and selectively reduced to 3-phenylpropan-1-ol in 130 min 
under the standard conditions with a TOF of 438 h-1 (entry 7). In the same line, the reduction of 
nonanal, a long chain aliphatic aldehyde, by 14 resulted in selective and quantitative formation of 
nonan-1-ol in ca. 85 min (entry 8). 
Deactivated olefins were also subjected to transfer hydrogenation under the optimized standard 
conditions. In contrast with the above described results for carbonyl compounds, the catalytic 
activity for the transfer hydrogenation of cyclohexene follows the order 14 < 7 < 6 (entries 9–11). 
Unexpectedly, the neutral bromo complex [IrBr(cod)(MeIm(CH2)2OMe)] (6) having a functionalized 
NHC ligand with a flexible 2-methoxyethyl substituent exhibited good activity giving a 94% of 
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conversion in 120 min with a TOF of 471 h-1 (entry 9). This result improves those obtained for the 
transfer hydrogenation of alkenes with related NHC-iridium complexes.12e 
The selectivity commonly observed in competitive hydrogen transfer reduction of mixtures of 
alkenes and ketones or aldehydes often implies the selective reduction of C=O over the C=C 
bonds.31 However, in the case of α,β-unsaturated ketones the general observed trend in hydrogen 
transfer catalysis is the preferential reduction of the activated double bond over the C=O reduction.10 
In agreement with this, mixtures of saturated ketone32,33 and saturated alcohol12e,13c,34 (major 
component) are generally obtained although a limited number of transition-metal complexes produce 
the chemoselective reduction to allylic alcohols.35 
Transfer hydrogenation of benzylideneacetone by O-functionalized NHC iridium complexes 
produces 4-phenylbutan-2-one as a result of the selective reduction of the C=C bond (entries 12-14). 
The more active catalysts were those containing NHC ligands with a rigid 2-methoxybenzyl free 
arm. Interestingly, the neutral complex 7 is more active than the cationic complex 14 giving a 90 % 
conversion in 30 min with a TOF of 1817 h-1 (entry 13). In order to confirm the selective formation 
of 4-phenylbutan-2-one, the catalytic reaction was monitored by GC/MS and 1H NMR. Thus, the 
resonances at δ 7.47 and 6.66 ppm of the benzylideneacetone olefinic protons progressively 
disappeared and two new multiplets at δ 2.78 and 2.66 ppm, corresponding to the methylenic protons 
of the 4-phenylbutan-2-one, were observed. In addition, no evidence for the formation of the allylic 
alcohol product, 4-phenylbutan-2-ol, was obtained even heating at prolonged reaction times as it was 
observed with other transfer hydrogenation catalysts.36,37 The mechanism for the selective formation 
of 4-phenylbutan-2-one probably involves the 1,4-reduction of benzylideneacetone through a keto-
enol tautomerization (Scheme 1).38 
 
Jiménez, Fernández-Tornos, Pérez-Torrente, Modrego, Winterle, Cunchillos, Lahoz and Oro, manuscript for Organometallics 
 
 
 
19 
[Ir]
O
H
[Ir]
O
H
H
H O H H
H
O
[Ir]
O
O
H H
H
H
 
Scheme 1. Hydrogen transfer mechanism for the selective reduction of benzylideneacetone. 
 
Imines are harder to reduce by transfer hydrogenation catalysis than aldehydes and ketones and 
relatively few examples are known.39 Imine hydrogenation has several important drawbacks such as 
the imine nitrogen lone pair coordination to the metal center, that inhibit the η2−(C=N) coordination 
required for the insertion into metal–hydride bonds, or the poisoning effect of the resultant amines 
on the catalyst. However, recent progress in the field has led to the discovery of new catalytic 
systems with high activities for the hydrogenation of imines.40 
We have found that cationic complexes 13 and 14 are also efficient catalysts for transfer 
hydrogenation of imines being 14 considerably more active (entries 15 and 16). Thus, (E)-N-
benzylideneaniline was reduced to N-benzylaniline under the standard conditions reaching a 93% of 
conversion in 1h with a TOF of 931 h-1 (entry 16). To the best of our knowledge, the most active 
catalytic system described is the bis-NHC-Ir(III) complex [(NHC)CH2(NHC)IrI2(OAc)],13b having 
triazole NHCs with neopentyl wingtip groups, with a TOF of 6000 h-1. The activity of 14 is similar 
to the Shvo’s catalyst (TOF = 800 h-1),41 and better than triazole-NHC   iridium(I) complexes (TOF 
= 333 h-1),42 [RhI2(OAc)(n-BuIm(o-C6H4)Imn-Bu)] (TOF of 100 h-1)12d or [RuCl2(PPh3)(IPr(2,6-
py)IPr] (TOF = 213 h-1).43 Additionally, the reduction of (E)-N-benzylidenemethanamine by 14, a 
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harder substrate, took place a moderate rate even at 1 mol % catalyst loading with a TOF of 161 h-1 
(entry 17). 
 
Mechanistic Studies. The currently accepted putative mechanism for late-transition-metal-
catalyzed hydrogen transfer involves the participation of metal hydride species. H-transfer to the 
unsaturated substrate can take place through an outer sphere mechanism with the participation of a 
ligand in the catalytic reaction, metal–ligand bifunctional catalysis,10,44 or an inner sphere 
mechanism depending if the substrate coordinates to the metallic center during the catalytic process. 
In the later case, different mechanisms involving monohydride or dihydride species have been 
proposed.45 Studies on the mechanism of metal-catalyzed hydrogen transfer from alcohols to ketones 
by monitoring the racemization of (S)-α-deutero-α-phenylethanol have established that most iridium 
and rhodium catalysts follow a monohydride pathway.46 In the same way, Crabtree et al have 
observed the specificity of deuterium incorporation in the hydrogen transfer catalyzed by bis-NHC-
Ir(III) complexes using cyclohexanol-d1, which also support a monohydride mechanism.13c 
The rhodium and iridium catalysts featuring hemilabile O- and N-donor-functionalized NHC 
ligands required the presence of a base for catalytic activity and, according with the above 
observations, most likely follow a monohydride pathway with a neutral hydride/NHC as the 
catalytically active species. In order to gain insight into the mechanism of hydrogen transfer using 
O-functionalized-NHC iridium(I) complexes, we have tried to identify the key intermediates likely 
involved in the process. 
The relevant neutral alkoxo intermediates have been identified by NMR. Thus, when a suspension 
of [IrBr(cod)(MeIm(2-methoxybenzyl))] (7) in tetrahydrofurane-d8 was treated with 1 equiv. of 
NaiPrO a yellow-orange solution of [Ir(OiPr)(cod)(MeIm(2-methoxybenzyl))] (19) was immediately 
formed. The most significant features in the 1H NMR of 19 were the i-PrO- ligand, that was observed 
at δ 3.67 (-CH) and 0.95 (–CH3) ppm, the downfield shift of >CH2 resonance of the 2-
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methoxybenzyl fragment and the highfield shift of the olefin resonances of the cod ligand compared 
to 7. The ESI+ mass spectra of solutions of 19 in 2-propanol do not exhibit the molecular ion 
although the specie [19 - OiPr]+ was detected at m/z 503.1 (100%). When a 2-propanol solution of 
19 was heated at 65 ºC for a couple of minutes the formation of several unidentified hydride species 
was observed by NMR together with free cyclooctene, also detected by GC/MS, resulting from the 
hydrogen transfer to coordinated 1,5-cyclooctadiene. Interestingly, when compound 19 was heated 
in the presence of cyclohexanone, an external hydride acceptor, cyclohexanol and acetone were 
identified in the reaction mixture. In the same way, the formation of the alkoxo compound 
[Ir(OCy)(cod)(MeIm(2-methoxybenzyl))] (20) was observed in the reaction of 7 with NaOCy in 
TDF-d8. Solutions of 20 slowly decomposed at room temperature to give cyclooctene (NMR and 
GC/MS evidence). However, we have observed that 20 reacts quickly with 2-propanol in TDF-d8 to 
give 19 and HOCy in an alkoxide exchange reaction that is a key step in most of the inner-sphere 
mechanistic proposals. 
Ir
Br
N
N
OMe7
Ir
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N
N
OMe19
NaiPrO
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20
NaOCy iPrOH
 
Scheme 2. Synthesis and reactivity of complexes [Ir(OR)(cod)(MeIm(2-methoxybenzyl))]. 
 
The stability of the O-functionalized-NHC iridium(I) catalytic systems has been established by 
consecutive hydrogen transfer reactions. Thus, to the solution obtained from a catalytic run using 14 
/cyclohexanone/KOH in 2-propanol under the standard conditions (>90% conversion was attained in 
12 min) an additional 5 mmol of cyclohexanone were added subsequently. Monitoring of the 
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reaction by GC showed similar conversion after the same reaction time what is an indication of the 
catalyst stability. Interestingly, the 1H NMR of the solid residue at the end of the reaction allowed 
the identification of compound 19 as the resting state of the iridium catalyst. In addition, there was 
no evidence for the loss of imidazolium salt by reductive elimination in the likely [IrH(cod)(O-
NHC)] (21) (O-NHC = MeIm(2-methoxybenzyl)) intermediate. 
We have studied the in situ generation of the active species under catalytic hydrogen transfer 
conditions by ESI and MALDI-TOF mass spectrometry.47 The ESI mass spectrum of a 1x10-3 M 
solution of complex [IrBr(cod)(O-NHC)] (7) in 2-propanol under argon atmosphere (diluted with 
acetonitrile to 1x10-6 M, manual injection) showed the molecular ion protonated at m/z 583.1 (41%), 
and the peaks at m/z 203.0 (74 %) and 705.1 (57%) that correspond to the imidazolium cation [H-O-
NHC]+ and the bis-carbene species [Ir(O-NHC)2]+ probably generated under the operating 
conditions. The ESI mass spectrum after the addition of a solution of KOH (1:5), at room 
temperature or after heating at 80 ºC, was basically identical although a tiny peak at m/z 504.8 (10%) 
with the right isotopic distribution for the species [IrH(cod)(O-NHC)] (21) was observed (see 
Supporting Information). 
The excessive fragmentation observed under ESI conditions suggests the presence of metastable 
species. In order to get further information on the catalytic intermediates MALDI-TOF mass spectra 
were recorded in linear mode48 (Figure 3). The mass spectra of a 2-propanol solution of 7 showed 
the molecular ion at m/z 582.0 and the ion resulting from the loss of the bromo ligand [Ir(cod)(O-
NHC)]+, [7 – Br]+, at m/z 502.9. In addition, a peak at m/z 585.3 (overlapped with the first one) 
which isotopic distribution corresponds to [Ir(OiPr)(cod)(O-NHC)Na]+, [19 + Na]+, was also 
observed (Figure 3a). The mass spectra immediately after the addition of a solution of KOH (1:5) 
shows both overlapping ions and a tiny peak at m/z 526.0 that might correspond to the species 
[IrH(cod)(O-NHC)Na]+ ([21 + Na]+, Figure 3b). Interestingly, the spectrum recorded after 30 min of 
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the addition of the base shows exclusively the presence of [7 - Br]+ and [19 + Na]+ due to the 
complete transformation of 7 into the catalytic intermediates. 
 
 
 
Figure 3. Iridium species detected in the MALDI-TOF MS (linear mode) of an 2-propanol 
solution of: a) [IrBr(cod)(MeIm(2-methoxybenzyl))] (7); b) 7 plus KOH, 1:5 ratio, registered 
immediately at room temperature; c) 7 plus KOH, 1:5 ratio, registered after 30 min at room 
temperature.  
 
The detection of the hydride species 21 and the remarkable stability shown by complex 19, which 
was generated from 7 and 2-propanol under MALDI conditions, strongly support an inner-sphere 
transfer hydrogenation mechanism with a monohydride complex as the active catalytic species. The 
proposed mechanism compatible with the information obtained from the different performed 
experiments is depicted in Scheme 3. The first step is the β-H elimination from the alkoxo complex 
[Ir(OiPr)(cod)(O-NHC)] (19) to generate the neutral hydride intermediate [IrH(cod)(O-NHC)] (21) 
with the concomitant formation of acetone (step i). The coordination of the ketone substrate to the 
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unsaturated hydride complex (step ii) and the migratory insertion into the Ir-H bond (step iii) results 
in the formation of a new alkoxo complex. Finally, the protonation of the alkoxo ligand by 2-
propanol (solvent) results in the formation of the reduced substrate regenerating the starting alkoxo 
complex in an alkoxide exchange reaction (step iv). 
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Scheme 3. Proposed mechanism for the catalytic transfer hydrogenation of ketones. 
 
In order to investigate the potential participation of iridium(III) species in the mechanism we have 
synthesized the cationic hydride complex [IrHBr(NCCH3)(cod)(MeIm(2-methoxybenzyl))]+ (22) by 
reaction of 7 with 1 equiv. of HBF4 in acetone in the presence of 1 equiv. of acetonitrile (Equation 
2). The molecular structure of one cation of 22 together to the more significant bond distances and 
angles are presented in Figure 4. Although two crystallographically independent molecules were 
observed in the crystal structure, both were chemically identical with minor torsion angle 
differences. The whole cationic complexes resemble the structure of 7 where a hydride and an 
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acetonitrile ligand have been added below and above the metal coordination plane. Thus, the cationic 
complexes in 22 could be described as octahedral with significant distortions associated to the 
different steric ligand requirements and the chelate behavior of the cod molecule (C(1)–Ir–M(1) 
170.50(11), Br–Ir–M(2) 171.26(8), N(3)–Ir–H 164(2)º, mean values, (M(1) and M(2) represent the 
midpoints of the olefinic bonds C(13)-C(14) and C(17)-C(18), respectively). If compared with 7, the 
new ligands in the metal environment, together with the oxidation of the metal centre, originate 
slightly longer bonding distances for all ligands, particularly evidenced in the Ir-olefinic bonds (Ir–
M(1) 2.072(5) in 7 vs. 2.161(2) Å in 22, or Ir–M(2) 1.980(4) in 7 vs. 2.072(3) Å  in 22). This relative 
elongation is not particularly significant for the NHC ligand (2.035(4) in 7 vs. 2.049(3) Å in 22) 
which maintains identical symmetric bonding distances within the imidazole moiety. Complex 22 
features a very long Ir–N(3) bond distance trans to hydride, 2.156(3) Å, significantly longer than 
values found in other related acetonitrile-dihydride NHC-Ir(III) complexes (range 2.098–2.135(5) 
Å), where readily dissociable acetonitriles have been observed.3e 
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The 1H NMR of 22 in CD2Cl2 evidenced that the compound exists in solution as two non 
interconvertible isomers, 22a and 22b, in a 28/72 ratio. The major isomer 22b showed a somewhat 
broad resonance for the hydride ligand at δ -14.30 ppm and a labile acetonitrile ligand at δ 2.75 ppm 
that was found to undergo exchange with CD3CN. This dynamic behavior is probably due to the 
strong trans effect of the hydride ligand having an acetonitrile ligand in trans and consequently, 
22b is the isomer characterized by X-ray diffraction. In contrast, the minor isomer 22a is not 
dynamic and displayed sharp resonances both for the hydride and acetonitrile ligands at δ -14.51 
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and 1.24 ppm, and probably corresponds to the isomer having the bromo ligand trans to the hydride 
ligand. 
 
 
Figure 4. Molecular structure of one independent cation of [IrHBr(NCCH3)(cod)(MeIm(2-
methoxybenzyl))] [BF4] complex (22). (Organic hydrogen atoms have been omitted for clarity). 
Selected bond lengths (Å) and angles (º) for the two independent cations: Ir–Br 2.5040(8), 
2.5068(8); Ir–C(1) 2.052(5), 2.046(4); Ir–N(3) 2.162(4), 2.151(4); Ir–H(1) 1.596(10), 1.583(10); Ir–
C(13) 2.261(5), 2.253(5); Ir–C(14) 2.277(5), 2.281(5); Ir–C(17) 2.183(5), 2.183(5); Ir–C(18) 
2.182(6), 2.192(5); N(1)–C(1) 1.359(6), 1.357(6); N(2)–C(1) 1.366(6), 1.368(6); C(13)–C(14) 
1.376(7), 1.384(7); C(17)–C(18) 1.381(7), 1.391(8); Br–Ir–N(3) 85.85(11), 84.35(12); N(3)–Ir–C(1) 
94.07(18), 94.16(16); Br–Ir–C(1) 89.81(14), 89.37(14); N(3)–Ir–H(1) 166(3), 162(2); Br–Ir–H(1) 
104(3), 79(2); C(1)–Ir–H(1) 76(3), 78.1(17); C(1)–N(1)–C(2) 110.8(4), 111.1(4); Ir–C(1)–N(1) 
131.4(4), 131.5(3); Ir–C(1)–N(2) 124.4(3), 124.8(3); Ir–N(3)–C(21) 174.1(4), 174.6(4). 
 
Interestingly, the formation of 22 is reversible and the reaction with one equiv. of KOH, or even 
with water, gave the precursor iridium (I) compound 7. In full agreement with this, both compounds 
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7 and 22 exhibited identical catalytic activity for the transfer hydrogenation of cyclohexanone, which 
supports the participation of iridium (I) intermediates. 
 
The Influence of the Hemilabile Ligand on the Catalytic Activity. The hydrogen transfer 
catalytic activity exhibited by iridium complexes with donor functionalized NHC ligands of 
hemilabile character evidence that O-donor functionalized NHC ligands provide much more active 
systems that the corresponding N-functionalized ligands. Although the interplay of several factors 
could be responsible for the activity differences, the chelating effect of the ligands probably plays an 
important role. 
The greater coordination ability of the donor set in the N-functionalized NHC ligands became 
evident in the synthesis of the cationic complexes 17 and 18 where the NHC ligand is κ2-C,N 
coordinated trough the pyridine and dimethylamino fragments, respectively. In contrast, the methoxy 
fragment in the cationic complexes 13 and 14 remained uncoordinated, in spite of their potential for 
bidentate coordination, and the complexes were stabilized by the coordination of an acetonitrile 
ligand. As a mechanism through 18-electron pentacoordinated iridium (I) species is unlikely due to 
required coordination of the substrate, the dissociation of the hemilabile fragment of the NHC ligand 
could be a requisite for catalytic activity in order to drive the reaction through square-planar iridium 
(I) intermediates (Scheme 3).49  The easier dissociation of the coordinated acetonitrile ligand and the 
strong coordination ability of the N-donor functionalized NHC ligands for the iridium center could 
account for the different catalytic activity of both types of complexes. However, the modest catalytic 
activity of complexes 17 and 18 contrast with the exhibited by related iridium complexes containing 
quinoline-functionalized NHC ligands.50 On the other hand, the higher catalytic activity of the 
cationic complexes, [Ir(NCCH3)(cod)(O-NHC)]+, compared to the neutral bromo complexes, 
[IrBr(cod)(O-NHC)], is probably a consequence of the easier generation of the alkoxy intermediate 
species [Ir(OiPr)(cod)(O-NHC)] from the cationic acetonitrile complexes. 
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It became evident that the presence of a methoxy group with weak coordination ability on the 
functionalized NHC ligands has a considerable impact on the catalytic activity. However, this effect 
could be more probably associated to weak interactions in the forward and backward hydrogen 
transfer from the hydride intermediate [IrH(cod)(O-NHC)] (21) (hydride migration and β-H transfer, 
steps ii and i, respectively, Scheme 3) rather than to the interaction with the iridium center. The 
enhanced catalytic activity of complex 14 compared to 13 should be ascribed to the different 
flexibility of the O-functionalized NHC ligand. Then, the rigid 2-methoxybenzyl substituent in 14 
probably brings about the -OMe group close to the external coordination sphere of the iridium center 
more effectively than the highly flexible 2-methoxyethyl substituent (compound 13) as a 
consequence of a proximity effect. In order to test this hypothesis, we speculate about the catalytic 
performance of complexes having more rigid O-functionalized NHC ligands, as for example a 2-
methoxyphenyl substituted NHC ligand. 
The imidazolium salt 1-(2-methoxyphenyl)-3-methyl-1H-imidazol-3-ium iodide (23) was obtained 
as a white hygroscopic solid in excellent yield following the general method of synthesis for 
arylimidazole derivatives.51 The reaction of 23 with [{Ir(µ-OMe)(cod)}2] (0.5 equiv.) in 
tetrahydrofurane gave the iridium(I) complex [IrI(cod)(MeIm(2-methoxyphenyl))] (24) which was 
isolated as a yellow microcrystalline solid in good yield (Equation 3). Unfortunately, the attempts to 
prepare the cationic complex [Ir(NCCH3)x(cod)(MeIm(2-methoxyphenyl))]+ from 23 or using the 
silver-NHC complex were unsuccessful because of the compound was frequently obtained together 
with minor unidentified hydride species. 
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In line with our expectations, compound 24 is an efficient catalyst precursor for transfer 
hydrogenation of cyclohexanone with 2-propanol. A conversion of 92% was attained in 50 min, 
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under the standard conditions (catalyst:substrate:KOH ratio of 1:1000:5 in 2-propanol at 80 ºC), with 
an average TOF 1100 h-1. The catalytic activity of 24 is in the same range as the found for the related 
neutral complexes but, interestingly, slightly more active than 7 (TOF 824 h-1). Nevertheless, in 
addition to the expected ligand effect, the presence of a better leaving ligand (iodo vs bromo) could 
also contribute to the increase of the activity. In fact, a catalytic test with the system 24/AgBF4 (1 
equiv.), in order to generate the cationic complex in situ, gave a 92% conversion in 23 min under the 
standard conditions with a TOF of 2200 h-1, just a half-fold reduction in catalytic activity compared 
with 14 under the same conditions. 
The Role of the O-donor Hemilabile Fragment: DFT Calculations. In order to understand the 
superior catalytic activity of the complexes having O-donor functionalized NHC ligands we have 
studied the key steps of the proposed mechanism by DFT calculations. The unsaturated hydride 
intermediate [IrH(cod)(O-NHC)] (21) (O-NHC = MeIm(2-methoxybenzyl)) plays a crucial role in 
the catalytic cycle and thus, their generation from the alkoxo complex [Ir(OiPr)(cod)(O-NHC)] (19) 
by β-H elimination has been investigated in detail (step i, Scheme 3). It is worth of notice that the 
reduction of the substrate by this species (steps ii and iii) results in the formation of an alkoxo 
intermediate and thus it can be considered as the reverse process. 
β-H elimination from transition metal alkoxides is believed to occur via a mechanism analogous to 
that established for transition metal alkyls that involved the initial β-H transfer to an unsaturated 
metal center followed by elimination of the unsaturated organic compound.52 An alternative two-
step mechanism involving σ-bond metathesis followed by oxidative addition has been proposed in 
palladium chemistry.53 β-H elimination studies on ruthenium, rhodium and palladium alkoxide 
complexes have shown that the formation a metal vacant site prior β-H transfer is generally 
required.49,53,54 In the same way, β-H elimination in the octahedral mer-cis-[Ir(Cl)(H)(OMe)(PMe3)3] 
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compound is promoted by the solvent-assisted dissociation of the chloro ligand, followed by 
irreversible β-H transfer and dissociative substitution of formaldehyde by chloride.55 
The β-H elimination in square planar iridium(I) alkoxides has been studied recently by Macgregor 
and Vadivelu56 with regard to the reactions of trans-[Ir(OR)(CO)(PPh3)2] observed by Atwood57 and 
the related mechanistic studies by Hartwig and co-workers.58 The detailed mechanistic studies by 
Hartwig evidenced the involvement of 14-electron unsaturated species generated by phosphine 
dissociation. Calculations by Macgregor and Vadivelu on this mechanism have shown that the 
reaction proceeds via an agostic in-plane intermediate that leads to the rate limiting β-elimination 
process. Theoretical analysis on the alkoxo complex [Ir(OiPr)(cod)(O-NHC)] (19) have revealed that 
β-H elimination process is possible without the need of ligand dissociation. The analysis has been 
performed by DFT using the B3LYP functional and a 6-31G** basis set for all atoms but Ir for 
which the LANL2DZ basis and associated pseudopotential was used. The complex was not 
modelized and instead its full composition was used in the calculations. 
The geometry of the two isomers of the square planar alkoxo intermediate 19 is shown in Figure 5. 
Both isomers are virtually of the same energy being 19b, the isomer having the β-H of the alkoxo 
ligand directed towards the NHC ligand, only ∆G = +0.8 kcal/mol less stable than isomer 19a, with 
the β-H directed to the cod ligand. The possibility of some interaction between the β-H on the 
alkoxo ligand and the oxygen atom of the 2-methoxybenzyl substituent on the NHC ligand was 
analyzed by approaching this group and fully optimizing the resulting structure. This leads to a third 
isomer 19c, a rotamer in fact, which shows a close O…H interaction (2.98 Å) and a free energy of 
just +1.0 kcal above 19a and 0.2 above 19b. 
By approaching the H atom to the iridium center, in order to modelize the β-H elimination process, 
the intermediate 19’ was found. This intermediate shows a significant agostic interaction of the β-H 
with the iridium center with distances of Ir…H = 1.86 Å and C…H = 1.19 Å. The formation of 19’ 
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requires the anticlockwise rotation about the Ir–O bond in 19c to facilitate the η2-CH interaction 
(Ir…C = 2.49 Å) which results in a constrained geometry of the alkoxo ligand (Ir–O–C = 84.7 o). The 
intermediate 19’ has a free energy of +26.6 kcal/mol relative to 19a, which is comparable to the 
found (ca. 30 kcal/mol) for agostic intermediates derived from iridium unsaturated species generated 
by ligand dissociation.56 Finally, the β-elimination process proceeds leading to the square planar 
hydrido complex [IrH(cod)(O-NHC)] (21), with a Ir-H bond distance of 1.64 Å, and the prompt 
elimination of ketone, this process releases a free energy of -6.5 kcal/mol relative to 19a. 
 
Figure 5. Relative free energies (∆G, kcal/mol) in the gas phase and geometries of the 
intermediate species for the β-H elimination in [Ir(OiPr)(cod)(MeIm(2-methoxybenzyl))] (19). 
 
The described results outline the role of the methoxy fragment of the substituent in the NHC 
ligand and its influence on the catalytic activity. The interaction between the β-H on the alkoxo 
ligand and the oxygen atom of the methoxy fragment results in a net destabilization of the alkoxo 
intermediate by a free energy of 1.0 kcal/mol, probably due to the induced steric effects. Thus, the 
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destabilization of 19 reduces the activation barrier leading to the intermediate 19’ facilitating the β-H 
elimination step in the catalytic process. This fact could explain the positive effect of the methoxy 
group of the functionalized NHC ligands on the catalytic activity. 
 
Conclusions 
Iridium(I) complexes having hemilabile O- and N-donor functionalized NHC ligands are efficient 
catalyst precursor for the transfer hydrogenation of unsaturated compounds in 2-propanol/KOH. The 
catalytic activity is strongly dependent on the donor function and flexibility of the backbone in the 
NHC ligands, as well as the charge of the complexes. Iridium complexes based on O-donor 
functionalized NHC ligands were found to be much more active than the corresponding N-
functionalized ligands which is related to the strong coordination ability of the dimethylamino donor 
set compared to methoxy, because of the dissociation of the hemilabile fragment is required for the 
formation of square-planar alkoxo iridium (I) intermediates. In fact, the higher catalytic activity of 
the cationic complexes compared to the neutral ones is also a consequence of the easier generation of 
the alkoxo intermediate species. Investigation of the reaction mechanism in combination with DFT 
calculations have allowed to disclose a potential role of the hemilabile fragment on the NHC ligands 
that could be responsible for the observed positive effect on the catalytic activity. The interaction 
between the β-H on the alkoxo ligand and the oxygen atom of the methoxy fragment of the NHC 
ligand, results in a net destabilization of the alkoxo intermediate that facilitates the β-H elimination 
step in route to the key hydrido intermediate species. 
 
Experimental Section 
Scientific Equipment. C, H and N analyses were carried out in a Perkin-Elmer 2400 Series II 
CHNS/O analyzer. Infrared spectra were recorded on a FT-Perkin-Elmer Spectrum One 
spectrophotometer using Nujol mulls between polyethylene sheets. NMR spectra were recorded on a 
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Bruker Avance 300, or a Bruker Avance 400 spectrometers. 1H (300.1276 MHz, 400.1625 MHz) 
and 13C (75.4792 MHz, 100.6127 MHz) NMR chemical shifts are reported in ppm relative to 
tetramethylsilane and referenced to partially deuterated solvent resonances. Coupling constants (J) 
are given in Hertz. Spectral assignments were achieved by combination of 1H-1H COSY, 13C APT 
and 1H-13C HSQC experiments. MALDI-TOF mass spectra were obtained on a Bruker 
MICROFLEX spectrometer using DCTB (trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-
propenylidene]malononitrile) as matrix.59 Electrospray mass spectra (ESI-MS) were recorded on a 
Bruker MicroTof-Q using sodium formiate as reference. Conductivities were measured in ca. 5 10-4 
M acetone solutions of the complexes using a Philips PW 9501/01 conductimeter. 
Organic compounds were identified by Gas Chromatography-Mass Spectrometry (GC/MS) using 
an Agilent 6890 GC system with an Agilent 5973 MS detector, equipped with a polar capillary 
column HP-5MS (df = 0.25 µm, 30m x 0.25 mm i.d.). The catalytic reactions were analyzed on an 
Angilent 4890 D system equipped with an HP-INNOWax capillary column (df = 0.4 µm, 25 m x 0.2 
mm i.d.) using mesitylene as internal standard. 
Synthesis. All experiments were carried out under an atmosphere of argon using Schlenk 
techniques. The solvents were distilled immediately prior to use from the appropriate drying agents 
or obtained from a Solvent Purification System (Innovative Technologies). Oxygen-free solvents 
were employed throughout. CDCl3, and CD2Cl2 were dried using activated molecular sieves, 
methanol-d4 (<0.02% D2O) was purchased from Euriso-top and used as received. MeImH (N-
methyl-imidazole) was obtained from Sigma-Aldrich and distilled prior to use. The substrates were 
obtained from common commercial sources and used as received, or re-crystallized or distilled prior 
to use depending on their purity. The imidazolium salts [MeImH(CH2)2OMe]Br (1),19 
[MeImH(pyridin-2-ylmethyl)]Br (3),20 and [MeImH(CH2)nNHMe2)]Cl2 (n = 2, 4; n = 3, 5)6a and the 
starting materials [{Ir(μ-Cl)(cod)}2]60 and [{Ir(μ-OMe)(cod)}2]61 were prepared according to 
literature procedures. 
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Preparation of 1-(2-methoxybenzyl)-3-methyl-1H-imidazol-3-ium bromide (2). N-
Methylimidazole (1.15 g, 14.0 mmol) was added to a solution of 2-methoxybenzyl bromide (14.0 
mmol, obtained in situ from 2-methoxybenzyl alcohol, 1.93 g, and PBr3, 1.33 g)21 in toluene (15 
mL) and the mixture refluxed for 12 h. The white solid formed was separated by decantation, 
washed with hot n-hexane and dried in vacuum. Yield: 97%. Anal. Calcd for C12H15BrN2O: C, 
50.90; H, 5.34; N, 9.89. Found: C, 51.23; H 6.01; N, 9.93. 1H NMR (298 K, CD3OD): δ 10.37 (s, 
1H, NCHN), 7.59 (dd, J = 7.4, 1.4, 1H, CH Ar), 7.51, 7.35 (m, 1H, 1H, CH Ar), 6.95 (td, J = 7.4, 
1.0, 1H, CH Ar), 6.91 (s, 1H, CH Im), 6.88 (s, 1H, CH Im), 5.47 (s, 2H, NCH2), 4.08 (s, 3H, OMe), 
3.89 (s, 3H, MeIm). 13C{1H} NMR (298 K, CDCl3): δ 157.45 (C Ar), 137.41 (NCHN), 131.49, 
131.48 (CH Ar), 123.33, 122.13 (CH Im), 121.32 (C Ar), 121.24, 110.97 (CH Ar), 55.79 (OMe), 
48.79 (CH2), 36.75 (MeIm). ESI-MS (CH3OH) m/z = 203.2 [M]+. 
General Procedure for the Preparation of [MBr(cod)(MeImXOMe)] (M = Rh, Ir; X = 
(CH2)2, CH2C6H4). The rhodium and iridium complexes containing methoxy-functionalized NHC 
ligands were synthesized through the following procedure. A mixture of [{M(µ-OMe)(cod)}2] (M = 
Rh, Ir) and [MeImHXOMe)]Br in THF (10 mL) was stirred overnight at room temperature to give 
an orange suspension. The solid was removed by filtration and the resulting orange solution was 
concentrated to evaporated to dryness. Treatment of the yellow residue with pentane rendered a 
yellowish solid which was separated by decantation, washed with pentane, and dried in vacuum. 
[IrBr(cod)(MeIm(CH2)2OMe)] (6). [{Ir(µ-OMe)(cod)}2] (270 mg, 0.407 mmol) and 
[MeImH(CH2)2OMe)]Br (180 mg, 0.814 mmol). Yield: 74%. Anal. Calcd for C15H24BrN2OIr: C, 
34.61; H, 4.65; N, 5.38. Found: C, 34.31; H, 4.59; N, 5.36. 1H NMR (298 K, CDCl3): δ 7.01, (d, J = 
1.9, 1H, CH Im), 6.77 (d, J = 1.9, 1H, CH Im), 4.71 (ddd, J = 13.9, 4.8, 3.5, 1H, NCH2), 4.58 (m, 
2H, CH cod), 4.36 (ddd, J = 14.1, 7.6, 4.3, 1H, NCH2), 3.90 (s, 3H, MeIm), 3.76 (m, 2H, CH cod), 
3.35 (s, 3H, OMe), 2.95 (ddd, J = 7.0, 7.0, 3.2, 1H, CH2O), 2.84 (ddd, J = 7.0, 7.0, 3.2, 1H, CH2O), 
2.17, 1.72, 1.49 (m, 4H, 2H, 2H, CH2 cod). 13C{1H} NMR (298 K, CDCl3): δ 180.16 (NCN), 
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121.72, 120.60 (CH Im), 84.49, 83.92 (CH cod), 72.12 (CH2O), 59.50 (OMe), 52.24, 51.99 (CH 
cod), 50.03 (NCH2), 37.34 (MeIm), 33.36, 33.24, 29.93, 29.74 (CH2 cod). MS (MALDI-TOF, 
DCTB matrix, CH2Cl2) m/z = 522.5 [M + H]+, 441.0 [M − Br]+. ΛM (acetone) = 16 Ω-1cm2mol-1. 
[IrBr(cod)(MeIm(2-methoxybenzyl))] (7). [{Ir(µ-OMe)(cod)}2] (125 mg, 0.188 mmol) and 
[MeImH(2-methoxybenzyl)]Br (107 mg, 0.377 mmol). Yield: 73%. Anal. Calcd for C20H26BrN2OIr: 
C, 41.23; H, 4.50; N, 4.81. Found: C, 41.38; H, 4.56; N, 4.80. 1H NMR (298 K, CDCl3): δ 
7.33−7.18, 6.93−6.80 (m, 2H, 2H, CH Ar), 6.70 (d, J = 1.6, 1H, CH Im), 6.65 (d, J = 1.6, 1H, CH 
Im), 5,53 (AB system, δA = 5.70, δB = 5.42, JAB = 14.7, 2H, NCH2), 4.61 (m, 2H, CH cod), 3.88 (s, 
3H, OMe), 3.80 (s, 3H, MeIm), 2.96 (br, 2H, CH cod), 2.13, 2.01, 1.70, 1.61, 1.48, 1.37 (m, 3H, 1H, 
1H, 1H, 1H, 1H, CH2 cod). 13C{1H} NMR (CDCl3): δ 178.37 (NCN), 155.23 (C Ar), 129.12, 127.22 
(CH Im), 124.82 (C Ar), 123.25, 121.12, 120.45, 110.25 (CH Ar), 83.85, 82.95 (CH cod), 55.24 
(OMe), 52.51, 52.02 (CH cod), 49.12 (NCH2), 37.51 (MeIm), 33.54, 32.21, 29.58, 28.12 (CH2 cod). 
MS (MALDI-TOF, DCTB matrix, CH2Cl2) m/z = 582.2 [M]+, 503.3 [M − Br]+. ΛM (acetone) = 14  
Ω-1cm2mol-1. 
[RhBr(cod)(MeIm(CH2)2OMe)] (8). [{Rh(µ-OMe)(cod)}2] (370 mg, 0.764 mmol) and 
[MeImH(CH2)2OMe)]Br (338 mg, 1.53 mmol). Yield: 64%. Anal. Calcd for C15H24BrN2ORh: C, 
41.78; H, 5.61; N, 6.49. Found: C, 41.42; H, 5.54; N, 6.30. 1H NMR (298 K, CDCl3): δ 6.95, 6.71 (s, 
1H, 1H, CH Im), 4.97 (m, 2H, CH cod), 4.81, 4.40 (m, 1H, 1H, >CH2), 4.11 (s, 3H, OMe), 3.76 (m, 
2H, >CH2), 3.28 (s, 3H, MeIm), 3.21 (br, 2H, CH cod), 2.26, 1.86 (m, 4H, 4H, CH2 cod). 13C{1H} 
NMR (CDCl3): δ 181.99 (d, JRh-C = 50.5, NCN), 121.96, 121.77 (CH Im), 98.00 (d, JRh-C = 6.5, CH 
cod), 97.82 (d, JRh-C = 6.6, CH cod), 72.13 (CH2O), 69.06 (d, JRh-C = 11.1, CH cod), 68.91 (d, JRh-C = 
11.0, CH cod), 58.97 (OMe), 50.48 (NCH2), 37.69 (MeIm), 32.77, 32.67, 29.15, 29.06 (CH2 cod). 
MS (MALDI-TOF, DCTB matrix, CH2Cl2) m/z = 431.2 [M]+, 351.8 [M − Br]+. ΛM (acetone) = 0.6 
Ω-1cm2mol-1. 
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[RhBr(cod)(MeIm(2-methoxybenzyl))] (9). [{Rh(µ-OMe)(cod)}2] (150 mg, 0.310 mmol) and 
[MeImH(2-methoxybenzyl)]Br (166 mg, 0.620 mmol). Yield: 90%. Anal. Calcd for 
C20H26BrN2ORh: C, 48.70; H, 5.31; N, 5.68. Found: C, 49.16; H, 5.68; N, 5.50. 1H NMR (298 K, 
CDCl3): δ 7.32, 6.94 (m, 2H, 2H, CH Ar), 6.78, 6.70 (s, 1H, 1H, CH Im), 5.60 (AB system, δA = 
5.74, δB = 5.46, JAB = 14.7, 2H, NCH2), 5.12 (m, 2H, CH cod), 4.11 (s, 3H, OMe), 3.88 (s, 3H, 
MeIm), 3.44 (br, 2H, CH cod), 2.37, 1.91 (m, 4H, 4H, CH2 cod). 13C{1H} NMR (CDCl3): δ 182.81 
(d, JRh-C = 50.0, NCN), 157.75 (C Ar), 130.78, 129.88 (CH Im), 125.18 (CH Ar), 122.50 (C Ar), 
121.12, 121.05, 110.89 (CH Ar), 97.84 (d, JRh-C = 6.7, CH cod), 97.70 (d, JRh-C = 6.7, CH cod), 
69.65 (d, JRh-C = 14.6, CH cod), 69.13 (d, JRh-C = 14.5, CH cod), 55.75 (OMe), 49.41 (NCH2), 38.06 
(MeIm), 33.47, 32.70, 29.75, 29.21 (CH2 cod). MS (MALDI-TOF, DCTB matrix, CH2Cl2) m/z = 
413.5 [M − Br]+, 203.5 [MeHIm(CH2)C6H4OMe]+. ΛM (acetone) = 1.4 Ω-1cm2mol-1. 
Preparation of [IrBr(cod)(MeIm(pyridin-2-ylmethyl))] (10). A mixture of [{Ir(µ-OMe)(cod)}2] 
(100 mg, 0.150 mmol) and [MeImH(pyridin-2-ylmethyl)]Br (76.6 mg, 0.302 mmol) in acetone (10 
mL) was stirred for 4 hours at room temperature giving an orange suspension. The solid was 
removed by filtration and the resulting solution was evaporated to dryness. The compound was 
extracted with diethyl ether and the solution concentrated to ca. 1 mL and then treated with n-hexane 
until a solid was formed. The orange solid was isolated by decantation, washed with n-hexane (2 x 2 
mL) and dried in vacuum. Yield: 81%. Anal. Calcd for C18H23BrN3Ir: C, 39.06; H, 4.19; N, 7.59. 
Found: C, 39.21; H, 4.15; N, 8.13. 1H NMR (298 K, CDCl3): δ 8.62 (d, J = 5.5 , 1H, CH py), 7.64 
(ddd, J = 7.9, 7.8, 1.7, 1H, CH py), 7.40 (d, J = 7.8, 1H, CH py), 7.17 (dd, J = 7.9, 5.5, 1H, CH py), 
6.86, (s, J = 1.9, 1H, CH Im), 6.75 (d, J = 1.9, 1H, CH Im), 5.53 (AB system, δA = 5.73, δB = 5.32, 
JAB = 14.6, 2H, NCH2), 4.65, 4.37  (br, 1H, 1H, CH cod), 3.91 (s, 3H, MeIm), 2.82, 2.69 (br, 1H, 
1H, CH cod), 2.22, 2.02, 1.61, 1.50 (m, 2H, 2H, 2H, 2H, CH2 cod). 13C{1H} NMR (298 K, CDCl3): 
δ 155.59 (C py), 150.74, 136.88, 123.58, 122.89 (CH py), 122.02, 120.38 (CH Im), 101.32, 99.58 
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(br, CH cod), 56.00 (NCH2), 52.75, 51.00 (br, CH cod), 37.65 (MeIm), 32.15, 31.50, 29.67, 28.36 
(CH2 cod). MS (MALDI-TOF, DCTB matrix, CH2Cl2) m/z = 554.1 [M + H]+, 474.0 [M − Br]+. ΛM 
(acetone) = 15 Ω-1cm2mol-1. 
Preparation of [IrCl(cod)(MeIm(CH2)nNMe2)] (n = 2, 3). [MeImH(CH2)nNHMe2)]Cl2 (0.301 
mmol) was added to a solution of [{Ir(µ-OMe)(cod)}2] (100 mg, 0.150 mmol) in tetrahydrofurane 
(10 mL) and stirred overnight. The resulting suspension was treated with NaH (7.22 mg, 0.301 
mmol) and H2O (0.1 mL) and stirred for 10 min. The solid was removed by filtration to give a 
yellow solution that was evaporated until ca. 1 mL. The pale yellow solids formed after treatment 
with n-hexane were washed with diethyl ether, separated by decantation and dried in vacuum. 
[IrCl(cod)(MeIm(CH2)2NMe2)] (11). Yield: 69%. Anal. Calcd for C16H27ClN3Ir: C, 39.29; H, 
5.56; N, 8.59. Found: C, 39.11; H, 5.32; N, 8.11. 1H NMR (298 K, CDCl3): δ 6.99 (d, J = 2.0, 1H, 
CH Im), 6.77 (d, J = 2.0, 1H, CH Im), 4.51 (m, 2H, CH cod and 1H, NCH2), 4.31 (m, 1H, NCH2), 
3.88 (s, 3H, MeIm), 2.91, 2.81 (m, 1H, 1H, CH cod), 2.70 (m, 2H, CH2N), 2.21 (s, 6H, NMe2), 2.14, 
1.72, 1.60, 1.51 (m, 4H, 1H, 2H, 1H, CH2 cod). 13C{1H} NMR (298 K, CDCl3): δ 180.05 (NCN), 
121.15, 120.06 (CH Im), 85.58, 84.32 (CH cod), 60.24 (NCH2), 53.15, 51.58 (CH cod), 49.78 
(CH2N), 44.85 (NMe2), 39.78 (MeIm), 35.56, 33.11, 29.10, 27.85 (CH2 cod). MS (MALDI-TOF, 
DCTB matrix, CH2Cl2) m/z = 489.0 [M]+, 454.0 [M − Cl] +. ΛM (acetone) = 14 Ω-1cm2mol-1. 
[IrCl(cod)(MeIm(CH2)3NMe2)] (12). Yield: 72%. Anal. Calcd for C17H29ClN3Ir: C, 40.50; H, 
5.81; N, 8.55. Found: C, 39.89; H, 5.76; N, 8.39. 1H NMR (298 K, CDCl3): δ 6.81 (d, J = 1.8, 1H, 
CH Im), 6.73 (d, J = 1.8, 1H, CH Im), 4.56−4.44 (m, 2H, CH cod and 1H, NCH2), 4.19 (ddd, J = 
15.1, 8.8, 6.6, 1H, NCH2), 3.88 (s, 3H, MeIm), 2.91, 2.80 (m, 1H, 1H, CH cod), 2.31 (m, 2H, CH2), 
2.21 (s, 6H, NMe2), 2.14 (m, 4H, CH2 cod), 1.92 (m, 1H, CH2), 1.75–1.42 (m, 4H, 4H, CH2 cod), 
0.78 (m, 1H, CH2). 13C{1H} NMR (298 K, CDCl3): δ 121.94, 120.61 (CH Im), 84.81, 84.60 (CH 
cod), 55.66 (NCH2), 52.30, 51.38 (CH cod), 47.86 (CH2N), 45.00 (NMe2), 37.61 (MeIm), 33.91, 
 
Jiménez, Fernández-Tornos, Pérez-Torrente, Modrego, Winterle, Cunchillos, Lahoz and Oro, manuscript for Organometallics 
 
 
 
38 
33.17 (CH2 cod), 32.15 (CH2), 29.96, 29.11 (CH2 cod). MS (MALDI-TOF, DCTB matrix, CH2Cl2) 
m/z = 504.2 [M + H]+, 468.2 [M + H − Cl]+. ΛM (acetone) = 10 Ω-1cm2mol-1. 
General procedure for the preparation of [M(NCCH3)(cod)(MeImXOMe)][BF4] (M = Rh, Ir; 
X = (CH2)2, CH2C6H4). AgBF4 (1 mmol) was added to a solution of the corresponding complex 
[MBr(cod)(MeImXOMe)] (1 mmol) in acetone (15 mL) and CH3CN (52 µL, 1 mmol). After 2 h of 
stirring at room temperature, the AgCl formed was filtered off to give a yellow solution. The solvent 
was pumped off and the dried oil residue was treated with cold pentane to give orange-yellowish 
solids which were separated by decantation, washed with pentane (2 x 2 mL) and dried in vacuum. 
[Ir(NCCH3)(cod)(MeIm(CH2)2OMe)][BF4] (13). [IrBr(cod)(MeIm(CH2)2OMe)] (6), (100 mg, 
0.190 mmol), AgBF4 (37.4 mg, 0.190 mmol). Yield: 67%. Anal. Calcd for C17H27BF4N3OIr: C, 
35.92; H, 4.79; N, 7.39. Found: C, 36.03; H, 4.80; N, 6.99. 1H NMR (acetone-d6): δ 7.37, 7.31 (s, 
1H, 1H, CH Im), 4.66 (br, 2H, CH cod), 4.53 (m, 2H, CH2O), 4.03 (s, 3H, OMe), 3.84 (m, 2H, 
NCH2), 3.70 (br, 2H, CH cod), 3.37 (s, 3H, MeIm), 2.62 (s, 3H, NCCH3), 2.30, 1.90 (m, 4H, 4H, 
CH2 cod). 13C{1H} NMR (acetone-d6): δ 130.13 (NCCH3), 123.12, 121.97 (CH Im), 82.73 (CH 
cod,), 71.27 (CH2O), 58.12 (OMe), 50.07 (NCH2), 36.85 (MeIm), 32.55, 29.27 (CH2 cod), 2.16 
(NCCH3). MS (MALDI-TOF, DCTB matrix, CH2Cl2) m/z = 439.1 [M − CH3CN]+. ΛM (acetone) = 
73 Ω-1cm2mol-1. 
[Ir(NCCH3)(cod)(MeIm(2-methoxybenzyl))][BF4] (14). [IrBr(cod)(MeIm(2-methoxybenzyl))] 
(7) (100 mg, 0.172 mmol), AgBF4 (33.4 mg, 0.172 mmol). Yield: 61%. Anal. Calcd for 
C22H29BF4N3OIr: C, 41.91; H, 4.63; N, 6.66. Found: C, 41.50; H, 4.65; N, 6.40. 1H NMR (298 K, 
acetone-d6): δ 7.73−7.22 (m, 3H, CH-Ar), 7.28, 7.09 (s 1H, 1H, CH-Im), 7.03 (dd, J = 7.1, 1H, CH 
Ar), 5.53 (AB system, δA = 5.55, δB = 5.51, JAB = 14.2, 2H, NCH2), 4.43 (br, 2H, CH cod), 4.01 (s, 
3H, OMe), 3.90 (s, 3H, MeIm), 3.53 (br, 2H, CH cod), 2.44 (s, 3H, NCCH3), 2.31, 1.80 (m, 4H, 4H, 
CH2 cod). 13C{1H} NMR (298 K, CD2Cl2): δ 179.51 (NCN), 157.33 (C Ar), 130.26, 129.91 (CH 
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Im), 129.56 (NCCH3), 123.20, 122.01, 120.00, 110.42 (CH Ar), 120.68 (C Ar), 83.39, 82.98, 65.98, 
63.78 (CH cod), 55.39 (OMe), 49.82 (NCH2), 37.59 (MeIm), 33.18, 32.23, 29.91, 29.19 (CH2cod), 
3.58 (NCCH3). MS (MALDI-TOF, DCTB matrix, CH2Cl2) m/z = 503.2 [M − CH3CN] +. ΛM 
(acetone) = 69 Ω-1cm2mol-1. 
[Rh(NCCH3)(cod)(MeIm(CH2)2OMe)][BF4] (15). [RhBr(cod)(MeIm(CH2)2OMe)] (8), (100 mg, 
0.232 mmol), AgBF4 (45.2 mg, 0.232 mmol). Yield: 65%. Anal. Calcd for C17H27BF4N3ORh: C, 
42.62; H, 5.68; N, 8.77. Found: C, 42.99; H, 5.90; N, 8.55.  1H NMR (CD2Cl2): δ 7.15, 7.04 (s, 1H, 
1H, CH Im), 4.87 (br, 2H, CH cod), 4.64 (m, 2H, CH2O), 4.04 (s, 3H, OMe), 3.81 (m, 4H, NCH2, 
CH cod), 3.38 (s, 3H, MeIm), 2.47 (m, 4H, CH2 cod), 2.31 (s, 3H, NCCH3), 2.08 (m, 4H, CH2 cod). 
13C{1H} NMR (CD2Cl2): δ 125.06 (NCCH3), 123.54, 122.56 (CH Im), 97.78, 77.75 (CH cod,), 
71.89 (CH2O), 59.18 (OMe), 50.86 (NCH2), 37.91 (MeIm), 32.46, 29.32 (CH2 cod), 3.41 (NCCH3). 
MS (MALDI-TOF, DCTB matrix, CH2Cl2) m/z = 351.7 [M − CH3CN]+. ΛM (acetone) = 81 Ω-
1cm2mol-1. 
[Rh(NCCH3)(cod)(MeIm(o-methoxybenzyl))][BF4] (16). [RhBr(cod)(MeIm(2-methoxy-
benzyl))] (9) (100 mg, 0.200 mmol), AgBF4 (38.9 mg, 0.200 mmol). Yield: 85%. Anal. Calcd for 
C22H29BF4N3ORh: C, 48.82; H, 5.40; N, 7.76. Found: C, 48.50; H, 5.65; N, 7.40. 1H NMR (298 K, 
CDCl3): δ 7.34 (m, 2H, CH-Ar), 6.99 (m, 2H, CH-Ar), 6.97, 6.91 (s 1H, 1H, CH-Im), 5.59 (br, 2H, 
NCH2), 4.67 (br, 2H, CH cod), 4.14 (s, 3H, OMe), 3.88 (s, 3H, MeIm), 3.49 (br, 2H, CH cod), 2.44 
(s, 3H, NCCH3), 2.26, 1.82 (m, 4H, 4H, CH2 cod). 13C{1H} NMR (298 K, CDCl3): δ 176.70 (d, JRh-C 
= 45.0, NCN), 157.37 (C Ar), 129.75, 129.52 (CH Im), 129.56 (NCCH3), 123.50 (C Ar), 123.00, 
120.78, 111.03, 110.42 (CH Ar), 99.17, 67.51 (CH cod), 55.51 (OMe), 49.85 (NCH2), 37.67 
(MeIm), 32.23, 28.18 (CH2cod), 3.58 (NCCH3). MS (MALDI-TOF, DCTB matrix, CH2Cl2) m/z = 
413.4 [M − CH3CN] +. ΛM (acetone) = 72 Ω-1cm2mol-1. 
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Preparation of [Ir(cod)(MeIm(pyridin-2-ylmethyl))][BF4] (17). The synthesis was carried out 
in two steps. Step 1: A mixture of [MeImH(pyridin-2-ylmethyl)]Br (3) (254 mg, 1.00 mmol), and 
Ag2O (116 mg, 0.5 mmol) was refluxed in dichloromethane (20 mL) for 90 minutes. The excess of 
Ag2O was removed by filtration to give a colorless solution of the NHC-silver complex. Step 2: The 
solvato complex [Ir(cod)(OCMe2)2]+ (1 mmol), prepared in situ from AgBF4 (195 mg, 1.00 mmol) 
and [{Ir(µ-Cl)(cod)}2] (336 mg, 0.500 mmol) in acetone (15 mL), was added to concentrated 
solutions of the NHC-silver complexes in CH2Cl2 (1 mL) obtained from step 1. The mixture was 
stirred for 3 h at room temperature to give a brownish suspension. The AgX formed was filtered off 
to give an orange solution. The solvent was removed under vacuum and the residue treated with cold 
pentane several times to afford the compound as an orange solid which was separated by decantation 
and dried in vacuum. Yield: 77%. Anal. Calcd for C18H23BF4N3Ir: C, 38.58; H, 4.14; N, 7.50. 
Found: C, 38.57; H, 4.11; N, 7.51. 1H NMR (298 K, acetone-d6): δ 8.78 (d, J = 5.3, 1H, CH py), 8.09 
(td, J = 7.6, 1.5, 1H, CH py), 7.94 (m, 1H, CH py), 7.62 (ddd, J = 7.6, 5.3, 1.5, 1H, CH py), 7.49 (d, 
J = 1.7, 1H, CH Im), 7.24 (d, J = 1.7, 1H, CH Im), 5.75 (AB system, δA = 5.77, δB = 5.63, JAB = 
14.3, 2H, NCH2), 4.60, 4.46, 4.15, 4.07 (m, 1H, 1H, 1H, 1H, CH cod), 3.87 (s, 3H, MeIm), 2.45, 
2.15, 1.77 (m, 2H, 4H, 2H, CH2 cod). 13C{1H} NMR (acetone-d6): δ 173.47 (NCN), 152.90 (C py), 
151.86, 140.19, 126.53, 125.79 (CH py), 123.34, 121.62 (CH Im), 84.53, 83.70, 65.44 (CH cod), 
65.23 (NCH2), 58.77 (CH cod), 36.97 (MeIm), 32.76, 32.44, 29.84 (CH2 cod). MS (MALDI-TOF, 
DCTB matrix, CH2Cl2) m/z = 474.2 [M]+. ΛM (acetone) = 67 Ω-1cm2mol-1. 
Preparation of [Ir(cod)(MeIm(CH2)3NMe2)][BF4] (18). The compound was prepared from 
[MeImH(CH2)3NHMe2)]Cl2 (5) (120 mg, 0.500 mmol), Ag2O (57.9 mg, 0.250 mmol) and 
[Ir(cod)(OCMe2)2]BF4 (0.500 mmol) following the two-step procedure described above for 17. 
Yield: 60%. Anal. Calcd for C17H29BF4N3Ir: C, 36.83; H, 5.27; N, 7.59. Found: C, 36.98; H, 6.79; N, 
7.51. 1H NMR (298 K, CDCl3): δ 7.32 (s, 1H, CH Im), 7.01 (s, 1H, CH Im), 4.76 (m, 2H, CH2N), 
4.40 (m, 1H, NCH2), 4.25 (br, 2H, CH cod), 4.16 (m, 1H, NCH2), 3.93 (s, 3H, MeIm), 3.36 (m, 2H, 
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CH cod), 2.56 (s, 6H, NMe2), 2.35 (m, 1H, CH2), 2.30 (m, 4H, CH2 cod), 1.93 (m, 1H, CH2), 1.75 
(m, 4H, CH2 cod). 13C{1H} NMR (298 K, CDCl3): δ 173.62 (NCN), 123.37, 12183 (CH Im), 85.17, 
83.24, 70.70 (CH cod), 66.08 (NCH2), 65.32 (CH cod), 47.10 (CH2N), 44.20 (NMe2), 37.34 (MeIm), 
33.45, 32.10 (CH2 cod), 31.23 (CH2), 29.07, 26.60 (CH2 cod). MS (MALDI-TOF, DCTB matrix, 
CH2Cl2) m/z = 468.2 [M]+. ΛM (acetone) = 78 Ω-1cm2mol-1. 
Reaction of 7 with potassium isopropoxide. [IrBr(cod)(MeIm(2-methoxybenzyl))] (7) (20.0 mg, 
0.034 mmol) and K[OiPr] (2.79 mg, 0.034 mmol) were reacted in THF-d8 (0.5 mL, NMR tube) to 
give a solution of [Ir(OiPr)(cod)(MeIm(2-methoxybenzyl))] (19). 1H NMR (298 K, THF-d8): δ 7.43 
(d, J = 7.7, 1H, CH Ar), 7.33 (dd, J = 8.2, 7.7, 1H, CH Ar), 7.06 (d, J = 8.2, 1H, CH Ar), 7.04 (d, J = 
2.0, 1H, CH Im), 6.95 (d, J = 7.7, 1H, CH Ar), 6.93 (d, J = 2.0, 1H, CH Im), 5.77 (AB system, δA = 
5.91, δB = 5.64, JAB = 14.7, 2H, NCH2), 4.38 (m, 2H, CH cod), 4.06 (s, 3H, OMe), 3.95 (s, 3H, 
MeIm), 3.90 (m, 2H, CH cod), 3.67 (m, 1H, CH(CH3)2), 2.40, 2.22, 1.65 (m, 2H, 4H, 2H, CH2 cod), 
0.95 (dd, J = 5.6, 4.0, m, 6H, CH(CH3)2). ESI-MS (i-PrOH) m/z = 503.1 ([M − PrO]+, 100%). MS 
(MALDI-TOF, DCTB matrix, i-PrOH, linear analysis) m/z = 585 [M + Na]+, 503.1 [M − OPr]+.  
Reaction of 7 with sodium cyclohexanoxide. A suspension of [IrBr(cod)(MeIm(2-
methoxybenzyl))] (7) (20 mg, 0.03 mmol) and NaOCy (4.2 mg, 0.03 mmol) in THF-d8 (0.5 mL, 
NMR tube) was stirred at 298 K to give a orange solution containing [Ir(OCy)(cod)(MeIm(2-
methoxybenzyl))] (20). 1NMR (298 K, TDF-d8) data for 20: δ 7.39 (d, J = 7.5, 1H, CH Ar), 7.29 (t, J 
= 7.5, 1H, CH Ar), 7.13 (m, 1H, CH Ar), 7.00 (d, J = 1.8, 1H, CH Im), 6.92 (m, 1H, CH Ar), 6.89 
(d, J = 1.8, 1H, CH Im), 5.73 (AB system, δA = 5.63, δB = 5.84, JAB = 15.0, 2H, NCH2), 4.37 (m, 2H, 
CH-cod), 4.02 (s, 3H, OMe), 3.92 (s, 3H, MeIm), 3.47 (m, 1H, CH OC6H11), 3.16 (m, 2H, CH cod), 
2.19 (m, 4H, CH2 cod), 2.40 (m, 4H, CH2 OC6H11), 1.59 (m, 2H, CH2 cod), 1.54, 1.24 (m, 4H, CH2 
OC6H11),1.09 (m, 2H, CH2 cod), 0.91(m, 2H, CH2 OC6H11). 
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Preparation of [IrHBr(NCCH3)(cod)(MeIm(2-methoxybenzyl))][BF4] (22). HBF4·Et2O (27.8 
mg, 0.172 mmol) was added to a solution of [IrBr(cod)(MeIm(2-methoxybenzyl))] (7) (100 mg, 
0.172 mmol) in acetone (10 mL) and CH3CN (52 µL, 1 mmol). After 1 hour of stirring at room 
temperature the colorless solution was concentrated to ca. 1 mL. Treatment of the pale yellow 
residue with cold pentane rendered a yellowish solid which was separated by decantation, washed 
with hexane and dried in vacuo. Yield: 85.9%. Anal. calcd for C20H27N2OIrBrBF4: C, 35.83; H, 
4.05; N, 4.17. Found: C, 35.55; H, 4.55; N, 4.29. MS (MALDI-TOF, DCTB matrix, CH2Cl2) m/z = 
623.1 [M − H]+, 503.1 [M − H − Br − NCCH3]+. ΛM (acetone) = 77 Ω-1cm2mol-1. Isomer 22a: 1H 
NMR (253 K, CD2Cl2): δ 7.39 (t, J = 7.7, 1H, CH Ar), 7.19 (d, J = 7.0, 1H, CH Ar), 7.05 (m, 2H, 
CH Ar), 7.03, 7.00 (s, 1H, 1H, CH Im), 5.76 (AB system, δA = 6.45, δB = 5.07, JAB = 16.2, 2H, 
NCH2), 4.90, 4.54 (m, 2H, CH-cod), 3.99 (s, 3H, OMe), 3.94 (s, 3H, MeIm), 3.57 (m, 2H, CH2 cod), 
1.24 (s, 3H, NCCH3), 2.77, 2.15, 2.08 (m, 2H, 2H, 2H, CH2 cod), -14.51 (s, 1H, Ir-H). 13C{1H} 
NMR (253 K, CD2Cl2): δ 173.46 (NCN), 156.84, 142.45 (C Ar), 129.75 127.74 (CH Ar), 124.55 
(NCCH3), 120.78, 110.55 (CH Ar), 101.34, 98.75 (CH Im), 77.07, 75.47, 65.41, 62.95 (CH cod), 
55.67 (OMe), 51.96 (CH2), 39.19 (MeIm), 33.28, 29.95, 29.10, 27.87 (CH2 cod), 4.24 (NCCH3). 
Isomer 22b: 1H NMR (298 K, CD2Cl2): δ 7.38 (t, J = 7.8, 1H, CH Ar), 7.29 (d, J = 7.2, 1H, CH Ar), 
7.19 (d, J = 2.0, 1H, CH Im), 6.90 (m, 1H, CH Ar), 6.81 (d, J = 2.0, 1H, CH Im), 6.69 (d, J = 7.2, 
1H, CH Ar), 5.68 (m, 1H, CH cod), 5.40 (AB system, δA = 5.45, δB = 5.36, JAB = 14.0, 2H, NCH2), 
5.45 (m, 1H, CH cod), 4.45, 4.21 (m, 1H, 1H, CH cod), 4.15 (s, 3H, OMe), 3.92 (s, 3H, MeIm), 2.75 
(s, 3H, NCCH3), 2.67, 2.21, 1.92, 1.40 (m, 2H, 2H, 2H, 2H, CH2 cod), -14.30 (s, 1H, Ir-H). 13C{1H} 
NMR (253 K, CD2Cl2): δ 172.54 (NCN), 156.17, 143.37 (C Ar), 130.14, 127.14, (CH Ar), 124.39 
(NCCH3), 120.19, 110.10 (CH Ar), 102.96, 100.34 (CH Im), 83.07, 82.64, 75.65, 74.69 (CH cod), 
55.58 (OMe), 49.77 (CH2), 41.57 (MeIm), 35.44, 32.19, 30.71, 25.57 (CH2 cod), 2.60 (NCCH3). 
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Preparation of 1-(2-methoxyphenyl)-3-methyl-1H-imidazol-3-ium iodide (23). Methyliodide 
(326 µL, 5.24 mmol) was added to a solution of 2-methoxyphenyl imidazole (900 mg, 5.24 mmol), 
prepared following the general procedure described by Zhang51 for the preparation of  
1-arylimidazoles, and the mixture was refluxed for 12 h. The yellow solid formed was separated by 
decantation, washed with hot diethyl ether and dried in vacuum. Yield: 85%. Anal. Calcd for 
C11H13IN2O: C, 41.79; H, 4.14; N, 8.86. Found: C, 41.33; H 4.09; N, 8.89. 1H NMR (298 K, 
CD3OD): δ 9.35 (s, 1H, NCHN), 7.88 (m, 1H, CH Im), 7.79 (m, 1H, CH Im), 7.62 (d, J = 7.6, 1H, 
CH Ar), 7.62 (d, J = 7.8, 1H, CH Ar), 7.36 (dd, J = 8.9, 1.2, 1H, CH Ar), 7.20 (td, J = 7.7, 1.2, 1H, 
CH Ar), 4.08 (s, 3H, OMe), 3.96 (s, 3H, MeIm). 13C{1H} NMR (298 K, CDCl3): δ 153.82 (C Ar), 
142.43 (NCHN), 133.14, 127.06 (CH Ar), 126.18 (C Ar), 125.02, 124.73 (CH Im), 122.50, 114.19 
(CH Ar), 57.04 (OMe), 37.13 (MeIm). ESI-MS (CH3OH) m/z = 189.3 [M]+. 
Preparation of [IrBr(cod)(MeIm(2-methoxyphenyl))] (24). [{Ir(µ-OMe)(cod)}2] (106 mg, 
0.160 mmol) and [MeImH(2-methoxybenzyl)]I (100 mg, 0.319 mmol) were reacted in THF (10 
mL). Work up as described above for compounds 6-9 gave the compound as a yellow brownish 
solid. Yield: 69%. Anal. Calcd for C19H24IN2OIr: C, 37.07; H, 3.93; N, 4.55. Found: C, 37.15; H, 
4.41; N, 4.87. 1H NMR (298 K, C6D6): δ 8.86 (dd, J = 7.7, 1.5, 1H, CH), 7.13 (ddd, J = 8.5, 7.7, 1.8, 
1H, CH), 6.94 (td, J = 7.7, 1.3, 1H, CH), 6.63 (d, J = 2.0, 1H, CH Im), 6.53 (dd, J = 8.5, 1.3, 1H, 
CH), 6.15 (d, J = 2.0, 1H, CH Im), 5.29, 5.23 (m, 1H, 1H, CH cod), 3.59 (s, 3H, MeIm), 3.13 (s, 3H, 
OMe), 3.10, 2.72 (m, 1H, 1H, CH cod), 2.13, 1.88, 1.63, 1.51, 1.34, 1.15 (m, 2H, 1H, 1H, 2H, 1H, 
1H, CH2 cod). 13C{1H} NMR (CDCl3): δ 181.47 (NCN), 153.55 (C Ar), 131.28, 129.57 (CH Ar), 
123.30, 121.14 (CH Im), 124.82 (C Ar), 120.53, 110.94 (CH Ar), 83.45, 81.57 (CH cod), 55.07 (CH 
cod), 53.61 (OMe), 53.45 (CH cod), 37.51 (MeIm), 34.03, 32.29, 30.91, 30.45 (CH2 cod). MS 
(MALDI-TOF, DCTB matrix, CH2Cl2) m/z = 615.1 [M]+, 488.2 [M − Br]+. ΛM (acetone) = 18 Ω-
1cm2mol-1. 
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General Procedure for Transfer Hydrogenation Catalysis. The catalytic transfer hydrogenation 
reactions were carried out under an argon atmosphere in thick glass reaction tubes fitted with a 
greaseless high-vacuum stopcock. In a typical experiment, the reactor was charged with a solution of 
the substrate (5 mmol) in 2-propanol (4.5 mL), internal standard (mesitylene, 70 µL, 0.5 mmol), base 
(104 µL, 0.025 mmol of a KOH solution 0.24 M in 2-propanol) and the catalyst (0.005 mmol, 0.1 
mol%). The resulting mixture was stirred at room temperature until complete solution of the catalyst 
and then placed in a thermostatized oil bath at the required temperature, typically 80 ºC. Conversions 
were determined by Gas Chromatography analysis under the following conditions: column 
temperature 35 ºC (2 min) to 220 ºC at 10 ºC/min at flow rate of 1 mL/min using ultra pure He as 
carrier gas. 
Calculation details. DFT calculations have been carried out with Gaussian 0962 using the B3LYP 
functional with a 6-31G** basis set for all atoms but Ir where the LANL2DZ basis set and 
pseudopotential has been used. The molecular structure was treated in full without any simplification 
of the ligands. Optimizations have been carried out using the “verytight” keyword and an “ultrafine” 
grid for integration. All the minima have been characterized by frequency calculations, all the 
intermediates, but 19’, show positive frequencies. For the intermediate 19’ a small negative 
frequency remains (-12.89 cm-1) which, by visual inspection, seems to be associated to a rotational 
movement on the ligands. 
X-ray Structural Determination of Complexes [IrBr(cod)(MeIm(o-methoxybenzyl))] (7) and 
[IrHBr(NCCH3)(cod)(MeIm(2-methoxybenzyl))][BF4] (22). Suitable crystals for the X-ray 
diffraction experiments were obtained at 273K for complex 7 by slow diffusion of pentane into a 
concentrated THF solution and for complex 22 by slow diffusion of diethyl ether into a concentrated 
acetone/acetonitrile solution. Intensity data were collected at low temperature (100(2)K) on a Bruker 
SMART CCD area detector diffractometer equipped with graphite-monochromated Mo-Kα 
radiation (λ = 0.71073 Å) using narrow frames (0.3˚ in ω). Cell parameters were refined from the 
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observed setting angles and detector positions of strong reflections (5259 refl., 2θ < 54.0º for 7, and 
6751 refl., 2θ < 53.96º for 22). Data were corrected for Lorentz and polarization effects, and a semi 
empirical absorption correction was applied using SADABS program.63 The structure was solved by 
Patterson method and completed by successive difference Fourier syntheses (SHELXS-86).64 
Refinement was carried out by full-matrix least-squares on F2 with SHELXL97,64 including isotropic 
and subsequent anisotropic displacement parameters for all non-hydrogen atoms. All hydrogen 
atoms were included from calculated positions and refined riding on their carbon atoms. For 22, high 
values of the Flack parameter suggested the existence of a partial component of a racemic twin, so 
this parameter was included as a free variable in the refinement; a final value of 0.234(5) was 
obtained. The hydride atoms in this second complex (22) were included in the last cycles of 
refinement from an electrostatic potential calculation and were refined with a light geometrical 
restriction affecting the Ir-H bond distance.  All the highest electronic residuals in both structures 
(smaller than 1.41 e/Å3) were observed in close proximity of the Ir metal and have no chemical 
sense. Atomic scattering factors, corrected for anomalous dispersion, were used as implemented in 
the refinement programs.64 
Crystal data for compound 7: C20H26BrIrN2O, M = 582.54; yellow block, 0.16 x 0.15 x 0.15 
mm3; monoclinic, P21/n; a = 14.346(2), b = 10.8182(17), c = 14.463(2) Å; β = 119.226(2)°; Z = 4; V 
= 1958.9(5) Å3; Dc = 1.975 g/cm3; µ = 8.866 mm-1, min. and max. transmission factors 0.245 and 
0.265; 2θmax = 54.20º; 12159 reflections collected, 4289 unique [Rint = 0.0301]; number of 
data/restrains/parameters 4289/0/228; final GoF 1.039, R1 = 0.0269 [3856 reflections, I > 2σ(I)], 
wR2 = 0.0651 for all data.  
Crystal data for compound 22: C22H30BBrF4IrN3O, M = 711.41; pale yellow block, 0.12 x 0.11 
x 0.09 mm3; monoclinic, P21; a = 14.611(3), b = 7.7625(16), c = 21.751(5) Å; β = 96.143(3)°; Z = 4; 
V = 2452.9(9) Å3; Dc = 1.926 g/cm3; µ = 7.122 mm-1, min. and max. transmission factors 0.482 and 
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0.567; 2θmax = 54.12º; 29262 reflections collected, 10682 unique [Rint = 0.0337]; number of 
data/restrains/parameters 10682/27/610; final GoF 1.051, R1 = 0.0265 [10389 reflections, I > 2σ(I)], 
wR2 = 0.0563 for all data.  
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The design of hydrogen transfer catalyst based on O- and N-donor functionalized NHC ligands 
having methoxy, dimetylamino and pyridine as donor functions, has allowed establishing the basis 
for the positive hemilabile effect observed for the catalytic reduction of a range of unsaturated 
substrates including ketones, aldehydes and imines. 
 
 
 
